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ABSTRACT 
 
Constipation is a serious problem in the pediatric population and often requires 
medical management with laxatives and enemas. Participants (2-10 years of age, n=13) 
with a history of mild constipation were assigned randomly to a fibre treatment or 
placebo group. After three weeks, subjects were crossed over to the other treatment. Pea 
hull fibre (4.0-7.6 g/day = 3.6-6.8 g/day of dietary fibre) was added to snack foods and 
an inulin supplement (5.0 g/day = 4.5 g/day of dietary fibre) was given, whereas the 
placebos were non-fortified snacks and maltodextrin (5.0 g/day).  
Subjects or their parents documented stool frequency, stool consistency, 
occurrence of abdominal pain and intake of snack foods and the supplement. Over the 
final two weeks, there was a trend towards an increase in the mean number of daily 
bowel movements in the fibre treatment group compared to the placebo group (n=11, 
0.68 ± 0.18 vs. 0.59 ± 0.26, p=0.064). Exclusion of one subject with diarrhea-type 
stools led to a significant difference between groups (n=10, 0.54 ± 0.18 vs. 0.67 ± 0.22, 
p=0.002). Stool consistency, using the Bristol Stool Form Rating Scale, showed no 
significant differences in stool consistency between groups (p=0.379) nor was there a 
difference in the incidences of abdominal pain (p=0.129). Not all subjects experienced 
abdominal pain. The inulin supplement (91% compliance rate; 1 serving per day) was 
consumed more consistently than were the snack foods fortified with pea hull fibre 
(77% compliance rate; 2 servings per day). There were no significant differences in the 
intake of the snacks or supplement when the placebo and treatment groups were 
compared. Energy intake was significantly lower during the fibre treatment period 
compared to placebo (n=12, 1307 ± 296 kcal/day vs. 1441 ± 285 kcal/day, p=0.035). 
ii 
 
The addition of pea hull fibre to typical snack foods and an inulin supplement to 
beverages were well accepted by children and no adverse effects were reported. Fibre 
fortification of snack foods with pea hull fibre and fibre supplementation of beverages 
with inulin may provide an alternative means to treat pediatric constipation. 
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CHAPTER 1 
INTRODUCTION 
 
1.1  BACKGROUND 
Most children do not consume an adequate amount of dietary fibre on a regular 
basis, regardless of the recommendation used for assessment (Nicklas, Farris, Myers, & 
Berenson, 1995; Saldanha, 1995; Hampl, Betts, & Benes, 1998; Monge-Rojas, & Rivas, 
2001; Kranz, Mitchell, Siega-Riz, & Smiciklas-Wright, 2005). Studies have shown that 
there is a link between low dietary fibre intake and constipation in children (Roma, 
Adamidis, Nikolara, Constantopoulos, & Messaritakis, 1999; Morais, Vitolo, Aguirre, 
& Fagundes-Neto, 1999; Ip, Lee, Chan, & Young, 2005). In addition to its laxation 
properties, dietary fibre has many health benefits, which are associated with higher 
intakes (Martlett, McBurney, Slavin, & American Dietetic Association, 2002; Kranz et 
al, 2005; Slavin, 2008). 
Historically, guidelines for dietary fibre intake in children have erred on the side 
of caution. It was thought that high amounts of dietary fibre would result in nutrient 
imbalances (McClung, Boyne, & Heitlinger, 1995). For example, phytates tend to bind 
minerals thereby reducing their bioavailability (Williams, 2006). However, previous 
research has not indicated support for this belief (McClung et al, 1995). Also, there has 
been concern that energy intake could be reduced (Williams, 2006); however, this may 
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be considered a benefit in the context of the current epidemic of pediatric obesity, 
which is becoming a concern even in developing countries.  
Traditional and a select number of novel sources of dietary fibre have been 
approved by the Canadian Food Inspection Agency for addition to regular foods. Two 
such fibre sources are pea hull fibre and inulin and both are approved for labeling 
purposes in Canada. Pea hull fibre has properties similar to those of refined wheat flour 
in terms of taste and texture, but has the added advantage of providing a significant 
amount of insoluble fibre. It can be used in many applications such as extruded cereals, 
pancakes, cookies, crackers and cereal bars. Inulin, a prebiotic, can be added to 
beverages such as yogurt drinks. Inulin is currently used in many food applications, 
primarily as a fat/sugar replacement or as a texture modifier.  
The use of both inulin and pea hull fibre would provide a two-pronged approach 
to improving constipation: pea hull fibre has proven laxation properties, whereas inulin 
promotes intestinal health with its own inherent overall health benefits. The intent was 
to mimic a regular diet, as most foods contain both soluble and insoluble fibre.  
Research in adult women has shown that dietary fibre intake is commonly 2:1, 
insoluble: soluble fibre (McEligot et al, 2002). In Brazilian children 4-14 years of age, 
it was found that the intake of dietary fibre for all subjects was in the range of 1.4-1.5:1, 
insoluble: soluble, regardless of frequency of bowel movements or level of dietary fibre 
intake (Paulo, Amancio, Morais, & Tabacow, 2006). The addition of either type of fibre 
(in supplement form) to a regular diet has been seen to be well-tolerated by children 
experiencing constipation (Castillejo, Bullo, Anguera, Escribano, & Salas-Saluado, 
2006; Loening-Baucke, Miele, & Staiano, 2004).  
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1.2  PURPOSE OF THE STUDY 
 The purpose of this study was to determine the effects of consumption of snacks 
fortified with pea hull fibre and beverages supplemented with inulin on the bowel habits 
of children with a history of constipation. To evaluate this, quantitative data on bowel 
movement frequency and consistency, as well as data on discomfort during the fibre 
treatment and placebo periods, were collected. 
 
1.3  OBJECTIVES 
This study will seek to achieve the following objectives: 
1. To determine the acceptance by children of foods fortified with pea hull fibre or  
inulin. 
2. To determine the effect of the consumption of foods fortified with pea hull fibre 
or inulin on the stool patterns and abdominal discomfort of children with a 
history of constipation. 
3. To determine if the consumption of foods fortified with pea hull fibre or inulin 
would help children achieve the recommended Adequate Intake for dietary fibre. 
 
1.4  HYPOTHESES 
Whereas fibre supplements have been investigated in children, to our knowledge 
no research has examined the addition of fibre to foods regularly consumed by children. 
Research on the effects of fibre-fortified food in children is currently lacking. 
Our hypothesis is that the consumption of foods fortified with pea hull fibre 
(cereal bars, crackers, snack cakes and cookies) and beverages supplemented with 
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inulin will significantly increase dietary fibre intake in children with a history of mild to 
moderate constipation. We further hypothesize that an increased fibre intake will 
increase stool frequency, improve stool consistency and decrease abdominal discomfort 
in these children. 
 
1.5  SIGNIFICANCE OF THE STUDY 
It is difficult to provide dietary counseling regarding high fibre diets due to a 
lack of commercially available and acceptable high fibre food products for children. 
Fibre fortification provides a means to increase fibre intake of children without having 
to make drastic changes to eating habits, which is often challenging. Research into the 
various types of dietary fibre has uncovered a whole host of beneficial physiological 
effects in humans. Because of this, one of the current consumer trends is an increase in 
the interest in high-fibre foods that are appealing and taste good, which is demonstrated 
by the increased number of high-fibre snack foods available on store shelves. 
 A low dietary fibre intake (Kimm, 1995) and constipation (Pashankar & 
Loening-Baucke, 2005; Misra, Lee, & Gensel, 2006) have also been linked to obesity in 
children. There may be advantages in this population for weight control due to the 
indigestibility of dietary fibre, in addition to laxation and intestinal health benefits. 
This study was intended to demonstrate the benefits of adding sources of fibre to 
everyday foods and beverages in order to maximize the benefits that various types of 
dietary fibre can provide. The majority of children in the general population consume 
inadequate amounts of dietary fibre from a diet low in plant foods and high in refined 
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foods. This study also was intended to demonstrate that high-fibre foods can be made 
appealing and desirable to children. 
 
1.6 SUMMARY   
 Low intakes of dietary fibre appear to be linked to constipation in childhood. 
Fibre fortification of snack foods and fibre supplementation of beverages may be 
beneficial for treating constipation. This study examined the effects of fibre fortification 
and supplementation on the bowel habits of constipated children, and on intakes of 
dietary fibre and energy. 
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CHAPTER 2 
LITERATURE REVIEW 
 
2.1  INTRODUCTION 
The normal range of bowel movements varies from individual to individual and 
can depend on age, type of food intake, medications, illness, and developmental and 
psychosocial factors (Coughlin, 2003). It is a widely held belief that most cases of 
constipation have no apparent organic cause (Youssef & Di Lorenzo, 2001), and this is 
often termed functional or idiopathic constipation. However, new research is suggesting 
that slow colonic transit time may account for some cases of so-called “functional” 
constipation (Southwell, King, & Hutson, 2005). Slow transit time is thought to occur 
as a result of colonic dysmotility (Hutson, McNamara, Gibb, & Shin, 2001; Southwell 
et al, 2005), although there is some controversy around this (Sherrington & Forbes, 
2005). It has been classified as a type of constipation since new techniques have 
become available for its diagnosis (Southwell et al, 2005).  
The characteristics of childhood constipation are different from those of adults. 
Youssef and Di Lorenzo (2001) highlight some of these important differences, such as 
that pediatric constipation is more common in males than in females, whereas the 
opposite is true in adults. Also, children tend to withhold stool as a common behaviour, 
whereas adults have more “straining” behaviours (Youssef & Di Lorenzo, 2001). With 
this withholding behaviour, soiling (sometimes called encopresis) occurs when stool 
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accumulates in the rectum and liquid stool starts to seep around the impaction (Youssef 
& Di Lorenzo, 2001).  
Health professionals often counsel a “high fibre diet” along with increased fluid 
and physical activity with families of children with constipation concerns. These 
recommendations are based more on tradition than on evidence-based medicine. 
However, some research has shown a role for dietary fibre in the management of 
constipation in children (Castijello et al, 2006; Loening-Baucke et al, 2004). 
Clarification is required as to who will benefit from what (e.g. dietary fibre, probiotics, 
prebiotics, osmotic laxative or lubricant), how much (daily or as needed) and for how 
long (prevention versus maintenance). Some information is available in the literature; 
however, more research is required to answer each of these questions. 
 
2.2  DIETARY FIBRE 
2.2.1 General Health Benefits 
There is much debate about the definition of dietary fibre and the methodology 
used for its analysis, as well as the benefits and risks associated with its consumption. 
The consumption of dietary fibre is associated with a number of health benefits 
(Martlett et al, 2002). It is known to aid in normal laxation and may be beneficial in the 
prevention of several disease states. Epidemiology has shown that fibre has a role in the 
prevention of cardiovascular disease, hypertension, stroke, obesity, some cancers and 
type 2 diabetes (Martlett et al, 2002; Slavin, 2008). Soluble fibre, in particular, is 
known to have a cholesterol-lowering effect (Hunt, 1993). Recently, other properties of 
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fibre, such as fermentability and viscosity, have emerged as potential properties which 
contribute beneficial physiological effects (Slavin, 2008). 
One of the challenges of studying the health benefits of fibre is that it is difficult 
to separate out the effects of fibre from the numerous other substances found in foods. 
Therefore, there is potential for a synergistic relationship between fibre and the other 
components, for example phytochemicals, found in fibre-containing foods that may 
contribute to its beneficial effects (IOM, 2002). For this reason, it is generally 
recommended to consume fibre from food sources, as opposed to supplements, with the 
exception of some therapeutic circumstances (Martlett et al, 2002). This will serve to 
ensure that all of the potentially helpful components are being consumed. 
Some fibre sources are recognized to produce laxation in a healthy population. 
Examples include cereal brans, psyllium and methylcellulose, which are sometimes 
commercially available as supplements (Slavin, 2008). A common effect observed with 
all of these fibre sources is an increase in stool weight, which occurs as a result of the 
fibre in the colon, by the water-holding abilities of the fibre and by the fermentation of 
the fibre by resident bacteria (Slavin, 2008). 
 
2.2.2 Definitions 
The Standing Committee on the Scientific Evaluation of Dietary Reference 
Intakes assembled a Panel on the Definition of Dietary Fibre to propose a definition for 
international use (see Table 2.1) (IOM, 2002).  
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Table 2.1  Definitions of Dietary Fibre 
Type of Fibre Definition Examples 
Dietary Fibre Consists of nondigestible 
carbohydrates and lignin that 
are intrinsic and intact in plants. 
Cereal brans, resistant starch 
(e.g. flaked corn cereal), 
raffinose, stachyose and 
verbacose in legumes, fructans  
in foods 
Functional Fibre Consists of isolated, 
nondigestible carbohydrates that 
have beneficial physiological 
effects in humans, typically 
added to other foods. 
Manufactured resistant starch, 
isolated oligosaccharides such 
as inulin or oligofructose, 
synthetically manufactured 
oligosaccharides, non-
digestible animal carbohydrate 
(e.g. connective tissue) 
Total Fibre The sum of dietary fibre and 
functional fibre. 
Both dietary fibre and 
functional fibre are considered 
in calculating total intake 
Adapted from: IOM. (2002) Dietary Reference Intakes for Energy, Carbohydrate, 
Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids 
(Macronutrients).Washington, DC: National Academies Press. 
 
It was deemed necessary to have two separate definitions to account for all types 
of dietary fibre such as the carbohydrate in plant cell walls and storage carbohydrates, 
carbohydrates from animal sources, and isolated or low molecular weight carbohydrates 
that are either natural or synthetic (IOM, 2002). Isolated fibres, such as inulin, are those 
that are manufactured from a natural food source. 
Further to these definitions, specific characteristics (some identifiable using 
analytical methods) have been attributed to dietary fibre in order to differentiate it from 
functional fibre. Functional fibre includes carbohydrates not recovered by alcohol 
precipitation and nondigestible mono- and disaccharides and polyols (IOM, 2002). They 
must come from intact/naturally-occurring food sources only, and be resistant to human 
enzymes. Certain resistant starches that have some or all of these characteristics are also 
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considered to be dietary fibre (IOM, 2002). Functional fibres are chemically, 
enzymatically or aqueously isolated, which includes manufactured resistant starch. 
The chemical properties of dietary fibre have been described as soluble or 
insoluble, which is based on analytical processing rather than physiological effects or 
composition (Dikeman & Fahey, 2006). This feature of fibre is problematic, as it is 
challenging to ascertain how the solubility of a fibre might behave differently in vivo 
compared to in vitro (Mongeau & Brooks, 2003). Also, methods for determining 
solubility vary and this can make it difficult to compare data from different countries. In 
the United States, regulation of dietary fibre is based on the analytical methods 
approved by the Association of Official Analytical Chemists International (Otten, 
Hellwig, & Meyers, 2006). In Canada, the Canadian Nutrient File (Health Canada, 
2007) is the major source for nutrient information and it is based on the USDA 
database, so by consequence the AOAC methods generally describe the fibre content of 
foods in Canada. 
Most fibre sources can be analyzed using the AOAC Method 985.29 (IOM, 
2001). However, this methodology is not applicable to certain functional fibre sources 
including resistant starch, nondigestible oligosaccharides (fructo- and galacto-
oligosaccharides) and polydextrose (Slavin, 2008). Methods for analyzing the fibre 
content of these fibre sources are in development (IOM, 2001).  
 
2.2.3 Composition 
Dietary fibre is found, for the most part, in plant-based foods. Dietary fibre is 
made up of carbohydrate and non-carbohydrate polymers (Mongeau & Brooks, 2003). 
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These are, generally speaking, the structural components of the plant. The carbohydrate 
polymers are often identified as nonstarch polysaccharides (NSP) in the literature. This 
serves to make the distinction between these and the starch components of plant-based 
foods.  
Recently, certain starch components, termed “resistant starch”, have been found 
to escape digestion in the small intestine and can be fermented in the colon, although 
there is some debate as to whether resistant starch is partially or completely fermented 
(Spiller, 1994; Tungland & Meyer, 2002). Examples of foods containing resistant starch 
include corn, potatoes, grains, bananas and legumes. The “resistance” to digestion of the 
starch in these foods tends to increase when the food is cooked and then cooled, for 
example when the amylose and/or amylopectin is retrograded (Spiller, 1994). It appears 
that the amylose molecule folds in on itself, rendering the α 1-4 bonds unavailable to α-
amylase (Spiller, 1994). 
In some cases, protein components of foods escape digestion and enter the 
colon, where they are fermented by the resident microflora in much the same manner as 
plant-based foods (Mongeau & Brooks, 2003). Examples of this would be connective 
tissue or chondroitin found in animal tissues (Tungland & Meyer, 2002). 
 
2.2.4 Physiological Effects of Dietary Fibre 
Dietary fibre and functional fibre are known to have a number of physiological 
effects along the gastrointestinal tract, including an effect on gastric emptying, satiety 
and fermentation (Hunt, 1993; IOM, 2001; Martlett et al, 2002; Spiller, 1994). These 
physiological effects are thought to play a role in the prevention of hyperlipidemia, 
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hypertension and coronary artery disease, as well as colorectal cancer, breast cancer, 
duodenal ulcer, constipation and laxation, and diverticular disease (Gray, 1995; Hunt, 
1993; Martlett et al, 2002). It should be noted that the role of dietary fibre in colorectal 
cancer is controversial at present (Martlett et al, 2002; Slavin, 2008). 
More recently, the physicochemical properties of fermentability and viscosity 
have been recognized as having beneficial physiological effects in humans. 
Fermentation occurs almost exclusively in the large intestine, as a result of dietary fibre 
escaping the small intestine. The degree of fermentation is variable and may be 
dependent upon the degree of polymerization, structural arrangement and solubility of 
the carbohydrate (Nyman, 2002). 
Examples of highly fermentable fibre sources include arabinoxylans in cereal 
grains and pectin in fruits and vegetables (Rose, DeMeo, Keshavarzian, & Hamaker, 
2007). When rapid fermentation occurs, the microflora are known to produce short 
chain fatty acids (SCFA) (Dikeman & Fahey, 2006). The SCFAs produced include 
butyrate, acetate and propionate, which are known to decrease the pH of the colon 
contents (Rose et al, 2007). In the context of bowel health, this has the effect of 
decreasing the proliferation of harmful bacteria (Rose et al, 2007). Furthermore, the 
production of butyrate provides a fuel source for epithelial cells of the large intestine 
with effects including a decrease in the inflammatory response (Rose et al, 2007).  
More slowly or incompletely fermented fibres, on the other hand, stimulate 
laxation by increasing stool weight and decreasing colonic transit time (Rose et al, 
2007; Dikeman & Fahey, 2006). These effects have the potential to increase fecal 
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output and the frequency of bowel movements (Rose et al, 2007). Non-fermentative 
fibre sources tend to increase the viscosity of the digesta (Malkki, 2001). 
Examples of viscous fibres are gums, pectins, psyllium and β-glucans (Dikeman 
& Fahey, 2006). These fibres thicken when mixed with fluids and have been shown to 
influence blood cholesterol and glucose levels, delay gastric emptying, and decrease 
small intestine transit time (Malkki, 2001). The literature on viscous fibres, as with all 
types of dietary fibres, is difficult to interpret due to differences in terminology and 
definitions (Dikeman & Fahey, 2006). 
 
2.2.5 Canadian Regulations 
The Canadian Food Inspection Agency governs food labelling practices in 
Canada. This agency uses definitions for fibre recommended in 1985 by the Expert 
Advisory Committee on Dietary Fibre, reporting to Health Canada (see Table 2.2), 
which have some similarities with those presented by the IOM. They both include two 
main types of fibre, one of which is “naturally-occurring” sources (dietary fibre), 
whereas the other covers manufactured or isolated types of dietary fibre (functional or 
novel fibre). 
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Table 2.2: Types of Fibre as Defined by the Canadian Food Inspection Agency 
Type of 
fibre 
 
Definition Composition Examples 
Dietary 
fibre 
The endogenous components 
of plant material in the diet, 
which are resistant to 
digestion by enzymes 
produced by humans. They 
are predominantly non-starch 
polysaccharides and lignin. 
The composition varies 
with the origin of the 
fibre and includes 
soluble and insoluble 
substances. 
 
Fruits, nuts, 
legumes and 
cereals, when 
traditionally 
processed or 
prepared. 
 
Novel fibre 
or novel 
source 
A food that has been 
manufactured to be a source 
of dietary fibre, and: 
i) has not traditionally been 
used for human consumption 
to any significant extent; or 
ii) has been chemically 
processed (e.g., oxidized) or 
physically processed (e.g., 
very finely ground) so as to 
modify the properties of the 
fibre; or 
iii) that has been highly 
concentrated from its plant 
source. 
 
It must be demonstrated 
that a novel fibre is safe 
and that it functions 
physiologically as 
dietary fibre for it to be 
considered a source of 
dietary fibre. 
 
Apple pomace, 
oat hull fibre, 
pea hull fibre, 
psyllium seed 
husk, sugar 
beet fibre. 
CFIA (2003). Retrieved from the Health Canada website on November 5, 2008: 
http://www.inspection.gc.ca/english/fssa/labeti/guide/ch6ae.shtml. 
 
2.2.6 Guidelines in Children 
There is some literature on the intake of fibre in children. No one single 
guideline would serve to encompass children of all ages and stages, due to the 
differences in their growth and development, as well as their energy requirements. One 
recommendation was proposed by the American Academy of Pediatrics Committee on 
Nutrition in 1993 and it was 0.5 g of dietary fibre per kilogram of body weight. 
However, this guideline never gained widespread use. 
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The most popular guideline, historically, is the one proposed by the American 
Health Foundation in 1995, which has become known as the “age plus 5 g” rule. For 
example, a 7 year old child should consume 12 g of dietary fibre daily (7 years old plus 
5 g = 12 g/d). This guideline was based on the results of NHANES II (1976-1980), as 
well as other national surveys in the U.S. The average fibre consumption at the time 
was 12 g/d, ranging from 8-15 g/d in the various age/sex groups (National Center for 
Health Statistics, 1983). At the time of this recommendation, it was not known that the 
dietary fibre intake of children was inadequate to achieve optimal health (IOM, 2001), 
which suggests that these targets may be set too low. 
Dietary fibre guidelines for intake in children have typically erred on the side of 
caution. There was insufficient data in children for the National Academy of Sciences 
committee to determine an EAR (Estimated Average Requirement) and thus an RDA 
(Recommended Dietary Allowance) for dietary fibre. Due to this, an Adequate Intake 
(AI) for dietary fibre was set using data extrapolated from adults. It is anticipated that 
the AI will meet or even surpass the requirements of most people in each life stage and 
gender group, however, it should be used with caution in making assessments of any 
type (Otten et al, 2006). Also, when usual intakes are compared to the AI of a nutrient, 
one can only conclude whether or not the intake is above the AI (Otten et al, 2006). 
For dietary fibre, the AI is based on energy intake and is calculated as 14 
g/1,000 kcal consumed. This level of dietary fibre consumption has been found to be 
protective against coronary heart disease in adults (Otten et al, 2006). Furthermore, the 
beneficial effects of fibre are believed to be related to the amount of food eaten (not to 
age or body weight) (IOM, 2002). On the other hand, energy requirements change 
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drastically throughout infancy, childhood and adolescence and most people would not 
know their usual energy intake (IOM, 2002). To make the recommendations more user-
friendly, survey data from the Continuing Survey of Food Intakes by Individuals 
(CSFII) from 1994-1996 and 1998 were used to calculate g/day of total fibre by 
multiplying the median energy intake for each age and gender group (Table 2.3). 
Individuals with higher or lower intakes would adjust the recommendation accordingly. 
 
Table 2.3  Adequate Intake for Total Fibre   
Based on 14 g/1000 kcal x Median Energy Intake 
Group Age (years) Total Fibre (g/day) 
1-3 19 Children: 
4-8 25 
Boys: 9-13 31 
 14-18 38 
Girls: 9-13 26 
 14-18 26 
 
The recommended intake based on the AI is substantially higher than the 
amounts recommended by the “age plus five” guideline. The following examples are 
intended to illustrate the differences between the AI and “age + five” guideline. A one 
year old should get 19 g of fibre per day based on the AI value, compared to 6 g/day 
based on the “age + five” guideline. Other examples of comparisons illustrate the 
differences between the two recommendations. For example, based on the AI, a 10 year 
old girl should get 26 g of fibre per day compared to 15 g (age + five guideline). An 18 
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year old male should get 38 g of fibre (AI) compared to 23 g (age + five guideline). The 
difference between the two can range from 11-15 g per day.  
It should be kept in mind that the AI takes into account the consumption of 
functional fibre sources, whereas previous guidelines did not. Some studies have used a 
hypothetical estimated intake of functional fibre of 5 g per day in children (Kranz et al, 
2005). In that case, the above-mentioned differences in recommended fibre intake for 
the two methods would be in the range of 6-10 g.  
The values for some sources of dietary fibre, particularly functional fibres, are 
not found in current nutrient databases (Kranz et al, 2005) (see section 2.2.4). It is 
therefore necessary to estimate functional fibre due to a lack of data, which may lead to 
over or underestimation.  
It was thought, at the time of publication of the AI for fibre, that human milk did 
not contain dietary fibre, and therefore was not required for health in infants (Otten et 
al, 2006). It has since been found that there is approximately 12 g of nondigestible 
oligosaccharides per litre of breast milk (Edwards & Parrett, 2003). Others have 
reported variable levels of oligosaccharides, such as 10-12 g/L (Veereman-Wauters, 
2005), 15 g/L (Brand-Miller & McVeagh, 1999), and 5-10 g unbound oligosaccharides 
per litre (Bode, 2006). Some of the differences in values are explained by daily 
variations in composition, duration of lactation and the mother’s genetics (Coppa et al 
1993). As breast milk is the optimal choice for nutrition for infants, a guideline for 
setting an AI for 0-6 month old infants could be based on the amount of non-digestible 
oligosaccharides in breast milk. 
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For example, a seven-kilogram infant would require approximately 700 kcal/day 
to meet energy requirements for growth, as well as deposition of body tissue. To meet 
this requirement, an intake of approximately 1000 mL of breast milk would likely be 
sufficient (68 kcal/100 mL, therefore, 680 kcal/d). The infant would, therefore, consume 
5-15 g of oligosaccharides daily, which translates into 7.5-22 g/1000 kcal consumed. 
Perhaps the average of this range could be selected as the AI recommendation, which is 
approximately 15 g/1000 kcal of energy intake for infants 0-6 months. Interestingly, this 
is similar to the current AI for other life stage/age groups. Additional research would be 
beneficial in confirming the amount of variation in the oligosaccharide content of breast 
milk. 
 For a one year old child who weighs about 10 kg, the energy requirement is 
about 1000 kcal/day. Breast milk intake will be reduced to about 500 mL/day (2.5-7.5 
g/day of oligosaccharides or an average of 5 g/day) or even less if whole cow’s milk is 
introduced, as is often the case in developed countries at this age. Introduction of cow’s 
milk, although common practice, may not be ideal due to the loss/decrease of 
oligosaccharides.  
It might be difficult to achieve an additional 10 g of dietary fibre (to get 15 
g/1000 kcal) for this child.  However, a study of the usual intakes of dietary fibre for 
American toddlers in 2002 (1-2 year olds, n=998) showed a mean intake of 8 g/day 
(Devaney, Ziegler, Pac, Karwe, & Barr, 2004). It seems that the AI may be achievable 
for children two years of age and beyond, particularly if breast milk is continued 
throughout the first two years of life, as recommended by the World Health 
Organization. 
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2.2.7 Fibre Intakes of Children 
 There are a number of studies providing information on the dietary fibre intake 
of children in North America, based primarily on nationwide intake data. Kranz et al 
(2005) examined data from the Continuing Survey of Food Intake by Individuals 1994-
1996, 1998 in the U.S. to determine the implications of the new Dietary Reference 
Intakes for fibre. It was found that children between 2-5 years of age consumed less 
than the recommended 14 g/1000 kcal of energy intake. In comparison, using the “age + 
five” rule for fibre intake, many still did not meet the minimum recommendation. 
 Earlier research also supports the inadequate fibre intake of many children. 
Using USDA data, Saldanha (1995) found that the majority of children in the various 
age-sex groups were not meeting the fibre intake recommendations as per the American 
Health Foundation. Further to this, they found that the intake of fibre dropped slightly 
from 1977-1978 to 1987-1988.  
 Another study by Nicklas et al in 1995 examined data obtained in the Bogalusa 
Heart Study. This was a large-scale epidemiological study spanning some 20 years, 
which followed a pediatric population into adulthood. The cross-sectional sample 
consisted of five cohorts of 10 year old children (1976, 1978, 1981, 1984, 1987). Sixty-
five percent of this group consumed a range of 5 to 15 g of dietary fibre per day 
(Nicklas et al, 1995).  
 A statistically significant higher dietary fibre intake was found in 1981 (6.0 
g/1000 kcal) compared to 1978 (5.3 g/1000 kcal). This is in contrast with the findings of 
Saldhana (1995) who observed a decrease in dietary fibre intake for three of the age 
groups (2-5 and 6-11 year old children and 12-18 year old males) from 1977-78 to 
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1987-88. The mean total daily dietary fibre intake stayed at approximately the same 
level throughout the study period.  
 The Bogalusa Heart study also identified and followed two cohorts of 13 year 
old children (1976, 1987). Once energy intake was adjusted, there was no significant 
difference in the dietary fibre intake of 13 year old children in 1976 versus 1987. 
Females aged 12-18 years maintained the same dietary fibre intake during this period. 
 There is some recent data on the intakes of Canadian children through the 2004 
Canadian Community Health Survey Cycle 2.2. It was found that 1-3 year old children 
(n=2117) consumed a mean of 10.2 g/day of dietary fibre, while 4-8 year old children 
(n=3235) consumed a mean of 13.5 g/day (Health Canada, 2006). The AI for the age 
groups mentioned is 19 and 25 g/d, respectively, which does not include functional fibre 
sources. This indicates a gap between the intake of Canadian children and the AI for 
dietary fibre, similar to that seen with American children. 
 The literature provides some information on the food sources of fibre in the diet 
of children. Kranz et al (2005) found that low-fibre fruits (e.g. canned/processed fruit 
such as fruit cocktail and applesauce) provided the most dietary fibre, followed by soy 
and legumes, high-fibre ready-to-eat cereals, high-fat grain-based mixed dishes (e.g. 
pizza), and high-fat salty snacks. Fresh fruit and vegetables were consumed in small 
amounts and contributed very little to fibre intakes. 
 An interesting finding by Kranz et al (2005) was that children who ate the most 
fibre also had the most nutrient-dense diets. For example, children aged 2-3 years old in 
the highest quartile of fibre consumption ate nearly double the servings of fruit and 
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grain products, when comparing them to those in the lowest quartile, supporting a 
possible relationship between foods high in fibre and nutrient density.  
 In contrast to North American children, dietary fibre intake was reported in 410 
Nigerian children and revealed a mean intake of 12 g for 2 year old children and 19.4 g 
for 5 year old children. These levels of dietary fibre intake are much higher than those 
reported for North American children. Interestingly, they still fall short of the DRI 
recommendations (e.g. 19 g dietary fibre/day for 1-3 year olds and 25 g/day for 4-8 year 
olds). Energy intakes were not reported in this study so energy-adjusted comparisons to 
the AI (i.e. 14 g/1000 kcal) cannot be made.  
 
2.2.8 Potential Side Effects of High Dietary Fibre Intake in Children 
Historically, guidelines for dietary fibre intake in children have erred on the side 
of caution. It was thought that high amounts of dietary fibre would result in nutrient 
imbalances (McClung et al, 1995). Many fibre-containing plant foods contain phytates, 
which have the ability to bind to minerals such as iron and calcium, thereby inhibiting 
their absorption. There is minimal data to support dietary fibre having detrimental 
effects on nutrient balances or growth (McClung et al, 1993; McClung et al, 1995; 
Williams, Bollella, & Wynder, 1995).   
One study has been performed in constipated children, which evaluated the 
safety of supplemental fibre. The subjects were allowed to choose from five different 
fibre supplements available commercially at the time of the study. The children, who 
were 4-12 years of age, were supplemented at a level of 0.25 g/kg body weight, which 
was half of the level recommended by the American Academy of Pediatrics 1993 
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guideline.  There were no significant changes in blood mineral levels of calcium, 
phosphate, copper and iron (McClung et al, 1993). Ferritin levels decreased in some 
subjects but no cause could be determined by the authors of this study. There has also 
been concern that energy intake would be reduced with a high intake of dietary fibre 
(Williams, 2006), although in the context of today’s childhood obesity epidemic, this 
may not be as concerning as it has been in the past. This study did not report any 
changes in energy intake. 
In fact, several animal studies have shown enhanced absorption of certain 
minerals such as calcium and magnesium (Coxam, 2005; Weaver, 2005). Additional 
clinical trials in humans are required to confirm the specific types of dietary fibre 
sources. Currently, fructans such as inulin and oligofructose are under investigation.  
It can be argued that receiving dietary fibre through food is preferred to fibre 
supplements. There is concern that excessive dietary fibre may be in some way harmful. 
However, it is interesting to note that no tolerable upper intake level (UL) was set for 
dietary fibre, which may indicate that there is no excessive intake. For example, if one 
considers the consumption of a glass of apple juice (no dietary fibre) compared to an 
apple, the sheer bulk of high-fibre foods is self-limiting (Kranz et al, 2005). Some 
experts argue, however, that the use of fibre supplements and the addition of fibre to 
foods may necessitate setting an UL in the future (Englyst, Liu, & Englyst, 2007).  
Research has demonstrated that two different fibre supplements were well-
tolerated in constipated children. One was a soluble fibre source (Loening-Baucke et al, 
2004) and the other an insoluble fibre source (Castillejo et al, 2006) (see section 2.6.3). 
No adverse events were reported in either study. 
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2.3  ISOLATED DIETARY FIBRE SOURCES 
2.3.1 Introduction 
There are a number of fibre sources that have been isolated for use in foods or as 
supplements. In Canada, the novel sources that are approved include apple pomace, oat 
hull fibre, pea hull fibre, psyllium seed husk and sugar beet fibre (see Table 2.2). Other 
isolated sources, such as inulin, are considered to be more traditional dietary fibre 
sources. 
 
2.3.2  Pea Fibre 
 Field pea is classified as a grain legume (pulse) with many properties similar to 
those of lentils (Grant, Duncan, Alonso, & Marzo, 2003). For example, the fibres from 
pea have the ability to bind bile acids (in vitro) (Grant et al, 2003). Also, there is some 
research suggesting that fermentation occurs in the colon with a resulting production of 
butyrate (in vivo) (Grant et al, 2003). Resulting actions of these characteristics in the 
host include laxation, as well as lowered cholesterol and blood glucose levels. However, 
the research is conflicting depending on the anatomical source of the fibre (e.g. testa or 
cotyledon), the preparation method (raw, cooked or extruded) and the type of peas used 
(yellow or green field peas). 
The finely ground testa, or hull as it is commonly referred to, of yellow field pea 
consists primarily of dietary fibre (e.g. Best Pea Fibre; Best Cooking Pulses, Portage La 
Prairie, MB, Canada; total dietary fibre 89%, insoluble 82%, soluble 7%). Best Pea 
Fibre is approved by the CFIA for addition to bakery goods and cereals only, and it is 
also permitted to label the dietary fibre content coming from ground pea hull fibre in 
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foods. In terms of its applications in the food industry, it is suitable as a replacement for 
wheat, soy, oat or sugar beet fibre. More specifically, it is touted as a good addition to 
foods such as noodles, cookies, muffins, graham crackers and other baked goods. 
One study using finely ground testa from yellow field peas has been performed 
in a group of institutionalized elderly (n=114). The pea hull fibre was added to 3-4 
foods per day and resulted in an increase in fibre intake of 1.9-6.4 g/day (mean = 3.1 
g/day). The results of this study indicated a significant increase in stool frequency with 
fibre supplementation in this population (Dahl, Whiting, Healey, Zello, & Hildebrandt, 
2003).  
A study performed by Guedon et al (1996) used 15 g/day of ground pea hull, 
which was sprinkled on food for three weeks. The findings of this study included the 
acceptability and digestive tolerance of pea hull fibre, although no change in stool 
frequency was observed (Guedon et al, 1996). The study was performed in six healthy 
young men with normal bowel habits. 
Dubois et al (1995) studied the effects of pea hull fibre (Sofalite F 179; Dasa, 
Torcy, France) and soybean fibre (hull) on cholesterol and lipid levels in six 
normolipidemic males. Each form of fibre was studied individually with an interval (7-
15 days) between test meals. The subjects consumed 10 g of pea hull fibre, which was 
composed of 0.94 g soluble fibre and 9.06 g of insoluble fibre. A nearly two-fold 
reduction in postprandial serum-esterified cholesterol over the time period of 0-7 hours 
was found following the pea fibre test meal.  
The authors surmised that this effect was due to the change in composition of 
the chylomicrons in the presence of the pea hull fibre, with a corresponding decrease in 
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the absorption of cholesterol as well as improved excretion of cholesterol in the small 
intestine (Dubois et al, 1993). This is an interesting finding in light of the lack of 
development of viscosity with pea hull fibre. Viscosity is thought to be the main 
modulator in lowering serum cholesterol levels (Dikeman & Fahey, 2006). The results 
also demonstrated a decrease in the overall postprandial serum cholesterol response, 
which remained significant at seven hours. Insulin response and postprandial 
triglyceridemia were not affected by the addition of either type of fibre (pea or soybean) 
to the control test meal. Additionally, these researchers found that chylomicron 
cholesterol levels were reduced significantly (by 31%) following the pea fibre meal. Pea 
fibre reduced postprandial HDL cholesterol levels and cholesterolemia for seven hours. 
It is proposed that this cholesterol-lowering effect lasts beyond the initial fibre 
supplementation (Dubois et al, 1995). Limitations of these studies included small 
sample size, male subjects only and short study length. 
A Danish study also looked at the addition of pea fibre to the diet and examined 
the effects on fasting blood lipid concentrations and on postprandial lipemia in two 
separate studies. The pea fibre was baked into bread and consumed by subjects in that 
form in both studies. The pea fibre contained 61.7 g of total dietary fibre per 100 g, 
which was 31.7 g of insoluble and 30.0 g of soluble fibre, consisting of intact pea cell 
walls with the majority of the starch removed (Sandstrom, Hansen, & Sorensen, 1994).  
 The first of these, study A, used 33 g of pea fibre (corresponded to 20 g dietary 
fibre) for a total daily dietary fibre intake of 36 g (20.7 g soluble and 15.3 g insoluble 
fibre) in five men and six women (crossover design). This was compared with a low 
fibre diet (17 g/day). They found that there was a tendency towards lower total 
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cholesterol concentrations in subjects after consuming the pea fibre diet. As a result, the 
ratio of total cholesterol to HDL cholesterol was significantly lower after the pea fibre 
diet (Sandstrom et al, 1994). Total and VLDL concentrations were also affected and 
were significantly lowered following the pea fibre diet (Sandstrom et al, 1994). 
The second study, study B, examined eight healthy male volunteers who 
consumed the pea-fibre-fortified bread at breakfast (12 g of pea fibre preparation, which 
provided 7.4 g dietary fibre) and lunch (15 g, which provided 9.3 g of dietary fibre). No 
significant differences were found in terms of plasma glucose levels, although plasma 
insulin levels were significantly reduced in the subjects following the consumption of 
the pea fibre diet compared to the control diet (Sandstrom et al, 1994). They also found 
that plasma triglyceride levels were reduced after the lunch meal with the pea fibre diet 
compared to the control (Sandstrom et al, 1994). Overall, significant effects were found 
with respect to insulin concentrations and triglyceride metabolism.  
 
2.3.2 Inulin 
 Inulin is a prebiotic fibre that has been studied extensively in the last several 
years. However, because this is an emerging area, discrepancies in terms of 
classification are rampant in the literature (Douglas & Sanders, 2008), even as the 
definitions for prebiotics are undergoing constant changes as new research is happening 
(Gibson, Prober, Van Loo, Rastall, & Roberfroid, 2004; Roberfroid, 2007). Douglas 
(2003) proposed three major groups of fructan prebiotics: short chain 
fructooligosaccharides (scFOS), oligofructose and inulin. Other authors suggest a 
broader term for these substances namely “resistant short-chain carbohydrates”, which 
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include the fructans (inulin and fructooligosaccharides), alpha-galactosides and other 
similarly manufactured compounds (Englyst et al, 2007). Inulin and oligofructose are 
the only currently recognized nondigestible oligossaccharides meeting all of the criteria 
required for “prebiotic” status (Roberfroid, 2007). 
  The criteria required for a substance to achieve prebiotic classification include: 
1) the resistance to digestion of the substance by gastric acidity, enzymes and 
absorption along the intestinal tract, 2) the fermentability (by intestinal bacteria) of the 
substance, and 3) the selectivity of the stimulation of intestinal bacteria with a benefit 
on the host’s health (Gibson et al, 2004; Roberfroid, 2007). A prebiotic, when ingested 
by humans, is a substance that promotes the growth of beneficial bacteria, such as 
bifidogenic and lactobacillic bacteria, in the intestines.  
Inulin is a naturally occurring oligosaccharide composed of fructose (Taylor & 
Mahenthiralingam, 2006). It is classified as a carbohydrate, specifically as a “fructan”, 
and it is derived from the roots of chicory and Jerusalem artichoke, and is also found 
naturally in foods such as onions, leeks, bananas and wheat.  Inulin derived from 
chicory root is approved for use as an ingredient by the Canadian Food Inspection 
Agency (section 2.2.5). 
 As part of the group of β(2→1) fructans, inulin has varying chain lengths and is  
resistant to digestion by human small intestinal enzymes due to its beta configuration 
(Roberfroid, 2002; Van Loo et al, 1995). The IOM has classified inulin as a functional 
fibre, as it has been isolated and has been shown to have beneficial physiological effects 
in humans (Douglas & Sanders, 2008). Oligofructose is a fructan that is enzymatically 
hydrolyzed from inulin (Roberfroid, 2002). The chain length of such prebiotics is 
28 
 
 
referred to as the degree of polymerization (DP) and for chicory inulin it is up to 25 
(Roberfroid, 2002), with the same author suggesting a DP of up to 60 in more recent 
years (Roberfroid, 2007). Oligofructose, when derived from chicory inulin, has a DP of 
only 3-5 (Van Loo et al, 1999), while other researchers suggest a DP of 2-8 
(Roberfroid, 2007).  
 The benefits of inulin are derived from its fermentation in the colon and are both 
local and systemic (Tungland & Meyer, 2002). It is fermented selectively by 
Bifidobacteria and Lactobacilli (Kruse et al, 1999; Causey, Feirtag, Gallaher, Tungland, 
& Slavin, 2000), which are of particular interest in human health (Douglas & Sanders, 
2008). They act by modifying intestinal health to a more healthful balance (Roberfroid 
et al, 1995) through a positive effect on colonic function and metabolism (Douglas & 
Sanders, 2008), as well as by minimizing proliferation of potentially harmful bacteria 
(Burkitt et al, 1974; Kruse et al, 1999). There is some research showing that there may 
also be stimulation of a Clostridium coccoides-Eubacterium cluster with the ability to 
produce butyrate (Kleessen et al, 2001). However, more research is required to 
elucidate which inulin derivatives have these effects (Roberfroid, 2005). 
 Inulin and oligofructose can increase stool frequency and stool mass due to their 
fermentation and resulting increase in bacterial mass (Roberfroid, 2002). Studies have 
shown that 1.5-2 g of stool weight can be achieved per gram of non-digestible 
oligosaccharides consumed (Gibson & Roberfroid , 1995; Den Hond, Geypens, & 
Ghoos, 2000).  
In a consensus statement report, Van Loo et al (1999) acknowledged that the 
role of oligosaccharides could be significant from a public health point of view. In 
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particular, the elderly and young children tend to experience constipation more 
frequently and may benefit from the ingestion of oligosaccharides. Inulin and 
oligofructose intake in the U.S. was estimated at 1-4 g/day compared to 3-11 g/day for 
Europeans (Van Loo et al, 1995). Intakes today would be expected to be higher given 
the increased use of inulin and FOS in the food industry; however, there is no data at 
present to confirm this. Research has shown that the prebiotic effect can be achieved 
with ingestion of 5-15 g/day over a few weeks (Roberfroid, 2002). 
 In terms of the side effects of inulin ingestion, Kruse, Kleessen, & Blaut (1999) 
found that some symptoms of flatulence and bloating were reported in individuals 
consuming 22-34 g/day (dependent on energy intake). The researchers reported that the 
side effects resolved within 2-4 weeks of ingestion of this level of inulin (Kruse et al, 
1999). This level is much higher than that typically consumed by Westerners and is also 
higher than necessary to achieve a prebiotic effect (see above). Also, study subjects 
reported that this level of gastrointestinal discomfort was acceptable (Kruse et al, 1999). 
 Another study in adults used inulin (DP ~25) in subjects with low stool 
frequency compared to a placebo diet. Fifteen grams of inulin was consumed over a 
period of two weeks and the side effects examined were abdominal cramps and 
flatulence. The authors found an increased incidence of each in the treatment group; 
however, this did not reach significance (flatulence: p=0.24; abdominal cramps: p=0.12) 
(Den Hond et al, 2000). 
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2.4  NORMAL BOWEL HABITS IN CHILDHOOD 
 2.4.1 Bowel Frequency and Stool Characteristics  
 A number of studies have been performed to determine the normal bowel habits 
of children. This can vary depending on a number of factors such as culture, usual diet, 
age and stage of development. Yong and Beattie (1998) determined by way of 
questionnaire that 84% of English children aged 4-11 years passed at least one stool per 
day. Based on symptoms identified by parents, 34% of these children had experienced 
constipation at some point and 5% had constipation for more than six months. Almost 
all children had a bowel movement frequency between three times per day and once 
every other day. Another British study, this time in a cohort of children aged 1-4 years 
(n=350), found that 96% had stool patterns between three bowel movements daily to 
one bowel movement every other day (Weaver & Steiner, 1984).  
 Another group studied Italian children aged 3-10 years and found a bowel 
movement frequency of 6.9 ± 2.6 stools per week (Paese, Staiano, Bausano, Cucchiara, 
& Corazziari, 1985). Based on these findings, the authors determined abnormal bowel 
frequency in this age group to be less than three times per week (or more than 14 per 
week). The sample size was relatively small (n=71) and may not be applicable to 
populations in other countries or cultures. However, similar results were found in 
another Italian study that looked at bowel frequency in children (Fontana et al, 1989), 
which serves to strengthen the earlier findings. In this study, subjects were divided into 
three age groups with larger sample sizes than performed by Paese et al (1985): 1-3 
years (n=105), 3-6 years (n=121) and 6 years and older (n=139). Their findings were 
consistent with Paese et al (1985), with 1-3 year olds having 1.4 stools per day, 3-6 year 
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olds having 1.1 stools daily and children 6 years and up having 1.0 stool per day 
(Fontana et al, 1989). The authors noted a wide range of inter- and intravariability in 
stool frequency.   
 A more recent Italian study reported bowel frequency in 3-12 year olds as being 
6.3 ± 2.5 evacuations per week (Corazziari, Staiano, Miele, Greco, & Italian Society of 
Pediatric Gastroenterology, Hepatology, & Nutrition, 2005). The study group was large 
for this age range (n = 2086) and they found no difference in stool frequency between 
the sexes for any age group. These researchers also examined the relationship between 
stool frequency and stool consistency. For all children, the mean bowel frequency had a 
statistically significant inverse relationship with increased stool consistency (p < 0.001) 
(Corazziari et al, 2005). For example, children whose stool was identified as being soft 
passed more bowel movements than those with hard or pellet-like stools. 
 A study of the bowel habits of American children aged 3-10 years of age was 
performed (Bloom, Seeley, Ritchey, & McGuire, 1993). Each age group was analyzed 
individually and the frequency of bowel movements was determined (see Table 2.4). As 
other studies have shown, frequency of bowel movements declines with age, as they 
found a statistically significant negative relationship between age and bowel frequency 
(per week). These findings are consistent with those reported by Paese et al (1985). 
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Table 2.4  Bowel Movements by Age Group* 
Age Group 
(years) 
Number of  
Patients 
Number of Bowel Movements per 
Week 
(mean ± SD) 
3 137 7.6 ± 2.7 
4 149 7.1 ± 2.5 
5 118 6.9 ± 2.4 
6 100 6.5 ± 1.7 
7 101 6.7 ± 2.0 
8 79 6.6 ± 2.4 
9 78 6.3 ± 1.9 
10 76 6.7 ± 2.2 
*Adapted from Bloom et al, 1993. 
Some studies have shown that there are no statistically significant differences in 
stool frequency between male subjects and female subjects for healthy preschool and 
school-aged children (Corazziari et al, 2005; Bloom et al, 1993). Others have studied 
children by age group only and have analyzed male and female subject data together 
(Fontana et al, 1989; Weaver & Steiner, 1984). 
Burmese children, aged 1-4 years, were studied by Myo-Khin, Thein-Win-
Nyunt, Kyaw-Hla, Thein-Thein-Myint, & Bolin (1994). The mean stool frequency in a 
cohort of children was 6.98 ± 1.94 per week. Of particular note in this study is that no 
statistically significant findings (in terms of stool consistency, weight and volume) were 
found between boys and girls and between age groups. A difference between diet 
(adult-type versus partially-weaned) and the observed stool characteristics was not 
found based on 7-day food records (Myo-Khin et al, 1994). However, dietary fibre 
intakes were not reported in this study. 
Thai children have also been found to have bowel frequency rates similar to 
those of their Western counterparts. Osatakul, Yossuk and Mo-suwan (1995) found that 
stool frequency for 2-3 year olds was 1.04 per day. However, mean stool volume (35.4 
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± 7.6 mL) produced by Thai children was higher than that reported by Western 
researchers (Osatakul et al, 1995). Weaver and Steiner (1984) found that British infants 
produced stool volumes of approximately 5-10 mL on average, while the majority of 
older children produced 25 mL of stool. This suggests that stool frequency, consistency 
and volume are important when considering bowel habits. The authors of the Thai study 
speculated that some of the differences in bowel habits of the Thai children could be 
due to higher dietary fibre intake (Osatakul et al, 1995).  
Walker and Walker (1985) also found differences in these bowel parameters, 
which they equated to differences in diet, particularly dietary fibre content (the 
relationship between stool characteristics and dietary fibre is discussed in section 2.6). 
They studied rural black children, urban black children and white children in South 
Africa who were 1-4 years old. They compared and contrasted these groups to 
determine geographic and/or ethnic differences. These researchers found that black 
children (whether rural or urban) had a statistically significant higher stool frequency 
than white children. The rural black children had 1.9 bowel movements per day and the 
urban black children had 1.8 bowel movements per day, whereas the white children had 
1.5 bowel movements daily (Walker & Walker, 1985).  
One other study examined defecation patterns and intestinal transit in Nigerian 
children (Akinbami, Erinoso, & Akinwolere, 1995). Four hundred and ten children 
between the ages of 6 months and 5 years of age were studied. The assessment tools 
employed included a questionnaire and carmine red marker, which was used to assess 
transit time. These authors found that the majority (95%) of subjects had a bowel 
movement 1-3 times per day with a steady decrease in the mean stool frequency with 
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advancing age (r = -0.8, p<0.01) (Akinbami et al, 1995). The range was found to be 
from once every other day to five times per day. Mean bowel movement frequency was 
reported in chart form in this study and is approximated as follows: for 6-11 month old 
infants, the mean frequency was 2.5 bowel movements (BMs) per day, for 12-23 month 
old toddlers the mean frequency was 2.1 BMs, for 24-35 month old toddlers it was 1.7 
BMs, and 1.4 BMs were reported for 35-60 month old children (Akinbami et al, 1995).  
Overall, the findings of these two studies (Akinbami et al, 1995; Walker, & 
Walker 1985) indicate higher stool frequency for African children compared to Italian 
children in similar age groups (Fontana et al, 1989; Corazziari et al, 2005; Paese et al, 
1985), Burmese children (Myo-Khin et al, 1994), British children (Weaver & Steiner, 
1984) and American children (Bloom et al, 1993). 
In a sub-group of 98 children in the study of Nigerian children, the mean transit 
time (mouth to anus) was found to be 18.3 hours with a range from 5.25 to 30 hours 
(Akinbami, 1995). A significant difference in transit time was found for children over 
three years of age (mean: 15.4 hours) compared to children less than three years of age 
(mean: 23.8 hours; p < 0.05). In terms of stool volume, it was found that 78% of the 
children (n=410) passed approximately 50-75 mL of soft stool, which is a great deal 
more than Thai (mean = 35.4 ± 7.6 mL) (Osatakul et al, 1995) and especially Western 
children (range = 5-25 mL) (Weaver & Steiner, 1984). This may be related to the higher 
dietary fibre intake (12-19.4 g/day) of the Nigerian children. 
The data from many of these studies is dated and it is possible that diet and stool 
characteristics have changed in the interim. However, this does provide a summary of 
the available data on bowel patterns in healthy children.  
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2.4.2 Intestinal Transit Time in Children and Adults 
Colonic transit time in children has not been studied extensively (Wagener, 
Shankar, Turnock, Lamont, & Baillie, 2004), although there are a few studies available 
using ingested radiopaque markers, particularly in constipated children (de Lorijn et al, 
2004; Gutierrez, Marco, Nogales, & Tebar, 2002). 
Wagener et al (2004) examined colonic transit time (CTT) in 22 healthy 
children (median age = 10 years, ranging from 4-15 years) and found a mean total CTT 
of 39.6 hours (SD = 21.4 hours, range = 7.2 - 86.4 hours). Results from six other studies 
were then used to compare their results. The researchers used various methods, 
populations and age groups to examine transit time, and the means for CTT range from 
22.4 to 37.8 hours (Wagener et al, 2004). One study in children and adults found that 
the mean transit time of adults was slightly longer compared to children but this did not 
reach significance (39 ± 5 hours vs. 29 ± 4 hours, t = 1.73; p = NS) (Arhan et al, 1981).  
Many factors in adults are known to affect transit time such as diet (Davies, 
Crowder, Reid, & Dickerson, 1986) and stress (Bouchoucha et al, 1992) but it is unclear 
if these effects are the same in children. Children with constipation do appear to have 
longer CTT than their non-constipated counterparts. For example, Gutierrez et al (2002) 
found a CTT of 29.08 ± 8.30 hours for 30 healthy controls compared to 49.57 ± 25.38 
hours for 38 constipated children (p<0.001).  
 It is difficult to compare data from the available trials due to the heterogeneity of 
the groups and the different methodologies employed. Also, large differences in inter-
individual variation were found even among healthy subjects with “normal” transit 
time. Due to this, research where subjects are compared to themselves may be more 
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valuable to establish baseline patterns in healthy subjects. One study examined the 
baseline (normal) transit time of 66 healthy adults and then induced constipation (slow 
transit) using loperamide and in turn induced diarrhea (rapid transit) with senna (Lewis 
& Heaton, 1997). It was found that the appearance of the stool (stool form) at baseline 
correlated highly with the whole gut transit time (WGTT) (r = - 0.54, p = 0.001) (Lewis 
& Heaton, 1997) and a tool, the Bristol Stool Form Scale, was developed. The authors 
concluded that this tool provides a valid means of assessing whole gut transit time. 
 
2.5  CONSTIPATION 
2.5.1 Definition and Proposed Diagnostic Criteria 
 Many research articles have been published on constipation. However, most are 
review papers and there is a relative paucity of original articles. This lends itself to a 
debate on the definition, evaluation, treatment and etiology of constipation.  
 Constipation has been defined in a number of ways in the literature. In a survey 
of 2680 Italian children, the criteria used for analysis of pediatric constipation were the 
Loening-Baucke (1993) criteria, which include at least two of the following: 
• Two or more encopresis episodes per week, 
• Periodic passage of very large amounts of stool once every 7-30 days, 
• A palpable abdominal or rectal mass on physical examination. 
Many groups have since devised their own criteria for diagnosis of constipation in 
children. 
The North American Society for Pediatric Gastroenterology and Nutrition 
(NASPHGAN) committee proposed that constipation is defined as a “delay or difficulty 
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in defecation, present for 2 or more weeks and sufficient to cause significant distress to 
the patient” (Baker et al, 1999). This group also evaluated the research literature in 
order to develop clinical practice guidelines (see section 2.5.3). 
There were no randomized controlled studies on the effects of dietary fibre 
supplements on stools at the time of publication by the NASPHGAN group. This group 
does, however, provide a level III guideline that “a balanced diet, containing whole 
grains, fruit and vegetables, is recommended as part of the treatment of constipation” 
(Baker et al, 1999). This level of evidence is not very compelling as it is based on the  
opinions of respected authorities with clinical experience, descriptive studies, and 
reports of expert committees.  
The most widely used diagnostic criteria for defecation disorders in recent years 
are known as the Rome II criteria. The American College of Gastroenterology Chronic 
Constipation Task Force (Brandt et al, 2005) argued that this tool is too unwieldy for 
use in clinical situations and that it better suits identification of a uniform study sample. 
The Rome II criteria have since been replaced by the Rome III version (Hyman 
et al, 2006), and changes were made which may address some of the concerns brought 
forward by the Task Force. For example, they reduced the timeframe of history of 
symptoms of functional constipation in infants and toddlers from 12 weeks to one 
month (Hyman et al, 2006). The duration of symptoms was also reduced for children 
and adolescents from three months to two months (Rasquin et al, 2006).  
The rationale behind this reduction in both cases was that it has been recognized 
that the earlier the diagnosis, the better the chance of success of the treatment (Evidence 
Level C) (Loening-Baucke, 1993; Van Ginkel et al, 2003). The authors further stressed 
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that diagnosis need only be made on the basis of history and physical assessment and 
does not require additional testing (Hyman et al, 2006). 
 
Table 2.5  Childhood Functional Defecation Disorders: ROME III Diagnostic 
Criteria* 
Disorder Features 
Infant dyschezia • Age less than six months and must include both of 
the following: 
• At least ten minutes of straining and crying before 
passage of soft stools 
• Infant is otherwise healthy 
Functional constipation 
(Infants and toddlers) 
 
• Must include one month of at least two of the 
following in infants up to 4 years of age: 
1. Stools passed ≤ 2/week 
2. At least one episode per week of incontinence after 
the acquisition of toileting skills 
3. History of excessive stool retention 
4. History of painful or hard bowel movements 
5. Presence of large fecal mass in the rectum 
6. History of large-diameter stools that may obstruct 
the toilet 
Functional constipation 
(Minimum of four years 
of age  developmentally; 
insufficient criteria for a 
diagnosis of irritable 
bowel syndrome) 
• Must include two or more of the following and 
criteria met must occur at least once a week for a 
minimum of 2 months prior to diagnosis 
1. Two or fewer defecations per week 
2. At least one episode per week of fecal incontinence 
3. History of retentive posturing or excessive stool 
retention 
4. History of painful or hard bowel movements 
5. Presence of a large fecal mass in the rectum  
6. History of large diameter stools that may obstruct 
the toilet 
*This chart has been adapted from Hyman et al, 2006 and Rasquin et al, 2006. 
The ACGCC Task Force, in their recommendations for an evidence-based 
approach to the management of chronic constipation, suggests a broader definition that 
contains the more typical symptoms communicated by patients. Brandt et al (2005), in 
their report, have proposed the following criteria for diagnosing chronic constipation:  
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Constipation is a symptom-based disorder defined as unsatisfactory defecation 
and is characterized by infrequent stools, difficult stool passage, or both. 
Difficult stool passage includes straining, a sense of difficulty passing stool, 
incomplete evacuation, hard/lumpy stools, prolonged time to stool, or need for 
manual maneuvers to pass stools (Grade C Recommendation)  (p.S8).  
Chronic constipation is further defined by this group as “the presence of these 
symptoms for at least three months” (Grade C Recommendation) (Brandt et al, 2005, 
p.S8). It should be noted that these recommendations considered the Rome II criteria, as 
the Rome III criteria were not yet published. In addition, this systematic review on 
constipation in adults did not specifically address pediatric constipation, which is 
known to have different characteristics compared to that of adults (Youssef & Di 
Lorenzo, 2001).  
Other agencies have proposed their own definitions and criteria for a diagnosis 
of constipation. The American Academy of Family Physicians describes constipation as 
bowel movements less often than every two days, or as stools that are hard or painful to 
pass along with more regular bowel movements. They further determine “chronic 
constipation” as occurring for two weeks or longer. The Canadian Paediatric Society 
(2007) describes the symptoms of constipation as bowel movements that occur less 
often than usual, that are hard and dry, and/or painful or difficult to pass.  
 Bosaeus (2004) in his review of the effects of fibre on intestinal function 
(diarrhea, constipation and irritable bowel syndrome) states that constipation is a 
constellation of symptoms including “low bowel frequency (i.e. < three/week), 
straining, painful, hard and/or dry stool, incomplete rectal evacuation, irregular stool 
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expulsion, and abnormally small stools”. However, this review was not specific to the 
pediatric population. 
 Yet another group has formed guidelines for the proposed terminology of 
constipation and related disorders (see Table 2.6). This group felt that the “current 
Rome criteria were too restrictive” (Benninga et al, 2005). The goal of this group was to 
reach a consensus on proposed terminology on childhood functional gastrointestinal 
disorders to facilitate the revision of the Rome II criteria. 
There has been some criticism of the PACCT definition of chronic constipation, 
as it does not encompass those patients who experience hard stools that may be 
described as pebble-like, scybalous, or cylindrical cracked (Maffei & de Morais, 2005). 
This part of the definition was previously proposed by “the Boston Working Group” 
(Hyams et al, 2002). Maffei and de Morais (2005) argue that this definition was broad 
enough to cover both mild and more severe cases of constipation. The Boston working 
group (Hyams et al, 2002) proposed the following definition:  
Constipation is a symptom defined by the occurrence of any one of the 
following, independent of stool frequency: passage of hard, scybalous, pebble-
like, or cylindrical cracked stools; straining or painful defecation; passage of 
large stools that may clog the toilet; or stool frequency less than three per week, 
unless the child is breast fed (p. S113). 
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Table 2.6  PACCT* Group’s Recommended Terminology  
Chronic Constipation The occurrence of two or more of the following 
characteristics, during the last 8 weeks: 
- Frequency of bowel movements less than three per week 
- More than one episode of fecal incontinence per week 
- Large stools in the rectum or palpable on abdominal 
examination 
- Passing of stools so large that they may obstruct the 
toilet 
- Display of retentive posturing and withholding 
behaviours 
- Painful defecation 
Fecal incontinence Passage of stools in an inappropriate place 
Organic fecal 
incontinence 
Fecal incontinence resulting from organic disease (e.g., 
neurological damage or sphincter abnormalities) 
Functional fecal 
incontinence 
Non-organic disease which can be subdivided into: 
– Constipation-associated fecal incontinence 
– Non-retentive (non-constipation-associated) fecal 
incontinence 
Constipation associated 
fecal incontinence 
Functional fecal incontinence associated with the presence 
of constipation 
Non-retentive fecal 
soiling 
The passage of stools in an inappropriate place, occurring 
in children with a mental age of 4 years and older, with no 
evidence of constipation based on history and/or 
examination 
Fecal impaction Large fecal mass in either the rectum or the abdomen is 
present which is unlikely to be passed on demand. The 
fecal impaction can be demonstrable by abdominal or 
rectal examination or other methodology. 
Pelvic floor dyssynergia Inability to relax the pelvic floor when attempting to 
defecate 
*PACCT: The Paris Consensus on Childhood Constipation Terminology (Benninga et 
al, 2005) 
 
       As mentioned, the many proposed definitions and diagnostic criteria make it 
challenging to compare the results of studies using different criteria. Future research 
would be greatly strengthened by a consensus among experts for evidence-based, 
pediatric-specific definitions for defecation disorders and constipation in particular. 
 
42 
 
 
2.5.2 Prevalence and Etiology 
Constipation results in a significant number of visits to doctors, and patients are 
often referred to specialists, such as pediatric gastroenterologists (Loening-Baucke, 
1993). Recently it was shown that 3% of all pediatric outpatient visits and 25% of 
gastroenterology referrals are related to constipation (Corraziari et al, 2005).  
Constipation should be viewed as a symptom and not a disease (Keshtgar, Ward, 
& Clayden, 2004). The majority of cases of constipation in children cannot be attributed 
to an organic cause (Castiglia, 2001). Therefore, approximately 95% are termed 
functional or idiopathic constipation (Coughlin, 2003). However, organic causes such as 
Hirschsprung’s disease, anatomic or neuromuscular irregularities, metabolic and 
endocrine disorders, and irritable bowel syndrome should be ruled out by an assessment 
performed by a physician, as these generally require treatment for the underlying cause 
of constipation (Youssef & Di Lorenzo, 2001).  
Most researchers agree that the cause of functional constipation is multi-factorial 
(Borowitz et al, 2003). The most common cause cited by parents was an episode of a 
particularly large and/or painful bowel movement (Borowitz et al, 2003). The other 
main causes reported by parents were toilet training, starting daycare, travel and the 
transition from a liquid diet (breast milk or formula) to a solid diet (Borowitz et al, 
2003).  
Other researchers also cite irregular bowel habits such as defecation avoidance 
or stool withholding (Candy & Edwards, 2003; DiPalma & Gremse, 2001), as a 
potential cause of constipation. In some cases, this might occur in a child who is so 
absorbed in activities that he or she continuously ignores the urge to defecate. This 
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results in some practitioners and researchers terming constipation as behavioural 
(Ozokutan, Zoroglu, Ceylan, & Ozban, 2005). However, this group found that there 
were no significant behavioural problems in children with constipation when compared 
with a control group of children with inguinal hernia (Ozokutan et al, 2005). 
If practiced over a long period of time, stool withholding can result in a 
condition termed “idiopathic megarectum” (Candy & Edwards, 2003). The rectum does 
not ordinarily serve as a storage place for stool but will begin to do so in these 
circumstances. The ability of the rectum to signal the time to defecate is lost and the 
result can be “overflow incontinence” (Candy & Edwards, 2003). This is sometimes 
misinterpreted as diarrhea by caregivers (DiPalma & Gremse, 2001).  
Researchers are looking at other possible causes of constipation. For example, 
low dietary fibre intake has been associated with increased risk of constipation (Morais 
et al, 1999) (see section 2.6.3). There are a number of other causes that have been 
proposed, such as inadequate physical activity or fluid intake, but there is an overall 
lack of evidence to support or refute these causes (Young, Beerman, & Vanderhoof, 
1998) (see section 2.5.3). 
Medications can also have an effect on the frequency and consistency of bowel 
movements. Some medications known to cause constipation in children include 
antacids, analgesics (e.g., NSAIDs), anticonvulsants (e.g. phenytoin), diuretics, 
chemotherapy drugs, antihistamines, some antihypertensives and anticholinergics (e.g. 
atropine agents) (DiPalma & Gremse, 2001). 
Slow transit constipation (STC) is emerging as a type of constipation previously 
considered “functional constipation”. Slow colonic transit time can be identified using 
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new techniques. For example, multi-channel colonic manometry measures the number 
of high amplitude propagating contractions (HAPCs), which are thought to correspond 
with mass movements (Southwell et al, 2005). Another tool, scintigraphy, involves 
neuropeptide labelling of food followed by imaging (Southwell et al, 2005). Both of 
these measures help to identify cases where slow colonic transit time may contribute to 
constipation. The etiology of STC is currently theorized to be related to abnormal 
intestinal innervation (Southwell et al, 2005). Based on this working theory and the fact 
that constipation tends to run in families, a pilot study was conducted and five genes 
were identified that encode neurotransmitters which may be involved in STC (Garcia-
Barcelo et al, 2007). Further research is required to elucidate these preliminary findings. 
Research in the last decade has pointed to chronic constipation potentially being 
a manifestation of food allergies. In particular, recent research has examined milk 
hypersensitivity as a symptom or potentially a cause of constipation (Iacono et al, 
1998), although further research on the role of milk hypersensitivity and constipation is 
required. Iacono et al (1998) studied 65 children with chronic constipation in a 
crossover design. These children had previously failed treatment with laxatives. They 
had a success rate of 68% (n=44) for children receiving soy milk and consuming a 
CMA-free diet (Iacono et al, 1998). This group attempted to aid in the adherence to the 
diet (i.e. CMP-free diet) by providing information and encouraging phone calls. 
Another group investigated twenty-five chronically constipated children to 
assess response to a CMP-free diet (Daher et al, 2001). Seven patients (28%) responded 
to the CMP-free diet and two infants were found to have allergic colitis following rectal 
biopsy. The lower success rate may be due to the small group size (Daher et al, 2001). 
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Also, the diet was not as carefully monitored so it is possible that food containing milk 
was consumed inadvertently by subjects. 
Twelve children with severe constipation who responded to a CMP-free diet 
were identified retrospectively. Nine patients were challenged with CMP after several 
months. Seven patients relapsed while two experienced no symptoms of constipation 
(Vanderhoof, Perry, Hanner, & Young, 2001). 
Fifty-two consecutive pediatric patients who did not respond to treatment for 
constipation were enrolled. Twenty-four subjects improved on the cow’s milk free diet, 
while an additional six improved on an oligoantigenic diet (a 45% success rate) 
(Carroccio et al, 2005). The food challenge was done in a double-blind, placebo-
controlled manner. Improvement was measured by stool frequency, as well as repeat 
rectal biopsy (baseline and after 12 weeks on the elimination diet). The findings 
included a significant increase in the mucus gel layer in subjects who responded to the 
cow’s milk free diet following the elimination diet compared to the baseline. All 30 
subjects who were successful on the elimination diet had normal rectal endoscopy 
results (Carroccio et al, 2005). There was a selection bias, as the majority of patients 
seen at this centre have food-related intolerances. 
Two very similar studies (conducted at the same centre) were performed by 
Scalici, Licastro, Manzoni, & Sferlazza (2005) and Iacono et al (2006). The first of 
these was done in 39 children with chronic constipation who were unresponsive to 
previous treatments and the second in 36 children. All of the subjects were placed on an 
elimination diet to exclude cow’s milk and milk products. Diagnosis of cow’s milk or 
multiple food intolerance was made on return of symptoms of constipation following 
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double-blind placebo-controlled food challenge. It was found that 17 patients in the first 
study and 14 subjects in the second study improved on the cow’s milk free diet. A 
further three subjects improved on the more restrictive diet (oligoantigenic diet) in both 
studies, and a 48% success rate in both studies was reported (Scalici et al, 2005; Iacono 
et al, 2006). 
Loening-Baucke (2005) performed a retrospective chart review. Of 185 infants 
less than two years of age, four were found to have cow’s milk allergy (CMA) 
(Loening-Baucke, 2005). Of these, two (1%) had also experienced constipation. This 
study did not include any form of food elimination or challenge to determine the 
presence of CMA, which could explain the low prevalence of constipation thought to be 
related to CMA (Heine, 2006). 
Although CMP allergy or intolerance may be implicated in chronic constipation 
in some children, the pathophysiology remains unknown. Animal studies have 
identified mast cells, eosinophils and T helper 2 cytokines, including Interleukin-13, as 
potential mediators of the allergy/intestinal dysmotility link (Murch, 2006). Some 
experts recommend that CMP intolerance should be considered in children who 
experience refractory constipation (Daher et al, 2001) but this remains controversial. 
Overall, supportive research demonstrates concomitant signs and symptoms of 
allergy/intolerance in some but not all study subjects, and additional research 
controlling for confounding factors such as dietary fibre intake is required. 
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2.5.3 Management and Treatment 
Typical therapeutic recommendations for constipation include increased fluid 
and fibre intake, increased physical activity, family/behavioural therapy and 
medications (e.g. laxatives, stool softeners) (Amendola, De Angelis, Dall’oglio, Di 
Abriola, & Di Lorenzo, 2003). There is an overall lack of research to support increased 
fluid intake and, in fact, one clinical trial in the pediatric population refutes this 
traditional recommendation (Young et al, 1999). One study also shows a lack of 
significant difference in fluid intake for constipated children compared to non-
constipated children (p=0.579) (Lee, Ip, Chan, Lui, & Young, 2008). 
One group of researchers found that a combined therapeutic approach was 
effective in treating constipation. This included guidelines for increasing water and fibre 
intake, laxative use, and family therapy using a multidisciplinary approach including a 
pediatrician and a psychologist. Their findings showed an improvement in behavioural 
patterns within one month and a resulting regularity of bowel movements in 88% of 
children at the three-month follow-up (Amendola et al, 2003). The sample size of this 
study was 25 children (mean age: 4.7 years; range 2.1 to 7 years).  
A 2001 Cochrane review found that the research was inadequate to recommend 
the use of stimulant laxatives in the treatment of constipation in children (Price & 
Elliott, 2001). The North American Society for Pediatric Gastroenterology, Hepatology, 
and Nutrition more recently found that stimulant laxatives such as senna and bisacodyl 
should only be used in the short-term (Level of evidence: II-3, see Table 2.7 for 
explanation) (NASPGHAN, 2006). 
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NASPGHAN (2006) also suggests that barley malt extract, lactulose, corn 
syrup, or sorbitol may aid in softening stools in infants (III). In children, lactulose, 
sorbitol, mineral oil and magnesium hydroxide are safe and effective treatments for 
constipation (I). However, for infants, mineral oil and stimulant laxatives are not 
recommended (III) (NASPGHAN, 2006). 
 
Table 2.7  Quality of Evidence Rating System 
Categories of the 
quality of evidence 
Description of the type of evidence 
I Evidence from a minimum of one well-designed randomized 
controlled trial 
II-1 Evidence from a properly designed cohort or case-control trial 
(no randomization) 
II-2 Evidence from well-designed cohort or case-control trials (more 
than 1 group/centre) 
II-3 Evidence from prospective or retrospective studies with or 
without intervention 
III Based on expert opinion such as clinical experiences or reports 
from expert committees 
Adapted from NASPGHAN, 2006.  
  Lactulose is marketed and sold as a laxative. It is synthetically derived from 
lactose through a heat treatment process (Pham & Shah, 2008), it is also thought to be 
bifidogenic (Salminen & Salminen, 1997), and it is known to be a nonabsorbable 
disaccharide (Chinda et al, 2004). It passes through the small intestine intact and is 
rapidly fermented by the resident microflora (Chinda et al, 2004). Based on its 
physiology, it could be considered a “dietary fibre-like” substance. It could possibly be 
considered in the future as a “functional fibre” based on the IOM classification (see 
section 2.2.2), as it could have similar beneficial physiological effects of other 
functional fibre sources such as inulin.  
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 In terms of long-term treatment, there is limited evidence to support the use of 
polyethylene glycol electrolyte (PEG) solution in difficult-to-treat cases of constipated 
children (III) (NASPGHAN, 2006). A combined approach using medications and 
behavioural therapy is well-supported (I) (NASPGHAN, 2006). Biofeedback therapy is 
an option for intractable constipation (II-2) (NASPGHAN, 2006). 
In infants, juices (e.g. pear, apple and prune juice) may decrease symptoms of 
constipation (II-3) (NASPGHAN, 2006). A balanced diet which includes whole grains, 
fruit and vegetables is recommended as part of the management of constipation in 
children (III) (NASPGHAN, 2006). This group did not analyze the data concerning 
dietary fibre intakes.  
  
2.5.4 The Impact of Constipation 
A large, prospective trial is required to establish a relationship between 
constipation and dietary fibre. However, some researchers suggest that such a study 
would have difficulty in obtaining funding due to the “benign” nature of constipation 
(Corkins, 2005). While there may be limited immediate effects on health, one could 
argue that the quality of life of children is adversely affected as a result of chronic 
constipation (Youssef et al, 2005).  Also, it is quite prevalent in the population, which 
makes it a pervasive problem, at the least. Finally, it has been found that constipation, if 
unresolved in children, can continue into adolescence and beyond (van Ginkel et al, 
2003), and it is assumed that the quality of life issues would continue. 
There has also been a proposal in the literature that chronic constipation can 
cause oxidative stress in constipated children. Markers of oxidative stress, such as levels 
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of vitamins C and E and activity of catalase and superoxide dismutase, were examined 
in constipated children (n=70) and sex- and age-matched healthy children (n=70). It was 
found that the constipated children had significantly decreased levels of vitamins C and 
E, as well as superoxide dismutase and catalase activity (Zhou, Lou, Zhou, & Wang, 
2005). The researchers surmised that this could indicate increased levels of oxidative 
stress in children with chronic constipation. The proposed mechanisms included 
increased exposure to the toxicants in stool for longer periods of time and resulting 
changes in the beneficial intestinal flora (Zhou et al, 2005). Another possibility is that 
the intakes of vitamins C and E are lower in constipated children, perhaps through an 
overall lower decreased energy intake secondary to a lack of appetite commonly found 
in this population. 
There is an additional consideration when determining the importance of 
research on constipation and dietary fibre. Links have been found in epidemiological 
data that show an inverse relationship between body weight and high dietary fibre 
intake in adults (Slavin, 2005). There may also be benefits in addition to alleviating 
constipation, as dietary fibre is thought to play a role in the prevention of cardiovascular 
disease, hypertension, stroke, obesity, some cancers and type 2 diabetes (Martlett et al, 
2002), which may relate to its impact on body weight. 
For example, Pashankar and Loening-Baucke (2005) recently found an 
increased prevalence of functional constipation in obese children. These researchers 
surmised that a number of factors may be responsible for this finding such as activity 
levels, diet or even hormonal fluctuations. A recent study examined the relationships 
between dietary fibre, constipation and overweight in a group of urban adolescents (de 
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Carholvo et al, 2006). They found that a dietary fibre intake below the “age + 5 
recommendation” was significantly associated with overweight in students attending 
private school (2.95, p=0.003 in females and 2.84, p=0.033 in males) (de Carholvo et al, 
2006). No statistically significant association between constipation and low dietary fibre 
intake was found in this particular study group based on odds ratio analysis.  
There may be a benefit for weight control with higher dietary fibre intakes in 
adults (Slavin, 2005), in addition to improved laxation and intestinal health. Dietary 
fibres cannot be digested in the human intestine, although most types are fermented by 
resident bacteria. This lack of digestion may be one of the mechanisms for lower 
obesity rates in populations that consume high amounts of dietary fibre (Kimm, 1995), 
as the decrease in energy absorption may be responsible for lower body weights. 
 
2.6 CONSTIPATION AND DIETARY FIBRE 
 2.6.1 Effect of Dietary Fibre on Bowel Movements 
Thai researchers looked at the relationship between bowel frequency and diet, 
particularly dietary fibre intake. They describe the Thai diet as a mixed diet with many 
different plant foods. Some of the foods given at an early age (6-12 months of age) 
include mashed bean, green leafy vegetables and pumpkin, foods that would not 
typically be introduced this early in a Western diet. The researchers suggested that this 
may explain the increased stool volume found in this population (Osatakul et al, 1995). 
However, in this study, the actual dietary fibre intakes were not reported. 
There have been two randomized studies using fibre supplements to treat 
constipation in children (Loening-Baucke et al, 2004; Castillejo et al, 2006). They were 
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both successful in significantly increasing stool frequency and improving constipation 
in a majority of study participants (see section 2.6.3 for details). 
Other researchers have attempted to elucidate the relationship between 
constipation and dietary fibre in children (Corkins, 2005; Guimaraes, Goulart, & Penna, 
2001; Ip et al, 2005; McClung et al, 1995). All except one of these studies (Guimaraes 
et al, 2001) found a relationship between low dietary fibre intake and constipation in 
children. However, these studies merely show a relationship and do not prove causation.  
A case-controlled study of Greek children (2-14 years old) found an incremental 
risk of constipation relative to lower dietary fibre intake (Roma et al, 1999). A similar 
study of Brazilian children (mean age 6.8 ± 3.2 years) found a lower intake of dietary 
fibre in the constipated group (13.8 g/d) compared to the control group (17.3 g/d) 
(p=0.020) (Morais et al, 1999). The children with the lowest intakes of dietary fibre 
(e.g. “age + 5 g” in this particular study) were more likely to experience constipation 
(odds ratio of 4.1; 95% confidence interval: 1.64-10.32) (Morais et al, 1999). 
The same group in Hong Kong examined the intake of plant foods to determine 
any association with the prevalence of constipation. Three day food records for 368 
children (3-5 years old), consisting of 28.8% constipated children based on Rome II 
criteria, revealed that the constipated group had a significantly lower intake of dietary 
fibre compared to the control group (p=0.044) (Lee et al, 2008). Further analysis 
revealed that this was likely related to a significantly lower intake of plant foods 
(vegetables, fruits and whole grain cereals) (p=0.034) (Lee et al, 2008). In addition to 
this, the constipated children had a corresponding lower intake of micronutrients 
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including vitamin C, folate and magnesium, which indicates an association between 
high fibre and nutrient dense foods. 
 
2.6.2 Effect of Particle Size on Laxation and Fermentation in the Colon 
There is some research investigating the effect of particle size of fibre on 
laxation. In one study, the effect of particle size on gastric emptying and small bowel 
transit in 12 subjects was investigated (Vincent et al, 1995). They confirmed that coarse 
bran significantly delayed emptying of the stomach, whereas fine bran did not. 
Increased small bowel transit time occurred but did not reach significance (Vincent et 
al, 1995).  
 Jenkins et al (1999) published two studies to address the effect of wheat bran 
particle size on both laxation and fermentation. The mean fecal output was similar for 
both fine and coarse wheat bran and significantly different from the control (p < 0.05). 
In terms of fermentation, this study employed breath methane testing in order to detect 
differences in colonic fermentation. Increased breath methane levels were found with 
fine wheat bran when compared with both the medium particle size and low fibre 
control treatments (p=0.025).  The authors suggest that these findings point to increased 
fermentation, that is increased fecal butyrate concentrations which are known to be 
beneficial for mucosal health (Jenkins et al, 1999). 
Similar findings in terms of increased stool bulk and fecal output were reported 
by Lewis and Heaton (1999) using inert plastic particles intended to mimic wheat bran. 
They did not find a significant difference in transit time between the “branlike flakes” 
and smaller granules (Lewis & Heaton, 1999). They did, however, find significant 
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changes in both groups with regards to improved stool form score, increased stool 
output and increased stool frequency (Lewis & Heaton, 1999). 
Overall, research points to a significant increase in stool output and fecal 
bulking, even when finely ground fibre sources are employed (Jenkins et al, 1999; 
Lewis & Heaton, 1999). There also appears to be an effect of increased stool frequency 
(Lewis & Heaton, 1999) and increased colonic fermentation (Jenkins et al, 1999). 
The delay in hunger and increased satiety brought on by a coarse dietary fibre 
could potentially be beneficial in weight reducing diets (Vincent et al, 1995). However, 
it could be detrimental in certain populations of children. In these instances, sources of 
finely ground dietary fibre may prove superior in the treatment of constipation. 
 
 2.6.3 The Treatment of Constipation with Dietary Fibre in Children 
There are two trials using fibre supplements in constipated children that have 
been published. Both are double-blind, randomized controlled trials. The first of these 
studies used a supplement composed primarily of soluble fibre (Loening-Baucke et al, 
2004) and the other a supplement composed primarily of insoluble fibre (Castillejo et 
al, 2006). Both of these products were added to other foods or beverages for 
consumption and no adverse events were reported.  Loening-Baucke et al (2004) 
studied 31 chronically constipated children using a multi-centre (US and Italy) 
crossover design with 4 weeks per treatment period. The fibre source used was 100 
mg/kg body weight glucomannan powder mixed with fluid. Glucomannan is a fibre gel 
polysaccharide composed of beta-1,4-linked D-glucose and D-mannose prepared from 
the tubers of the Japanese Konjac plant. Chronic functional constipation was defined as 
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occurring for six months or longer, difficulty or delay in defecation, duration of more 
than two weeks, and causing distress in the child (Loening-Baucke et al, 2004). 
Laxatives remained unaltered during the study period, although fecal impactions were 
cleared using enemas prior to study start, as well as at 4 and 8 weeks, if necessary. It is 
unclear in the study protocol whether or not a washout period was in effect. 
The mean age of study participants was 7 years (± 2 years).This study included 
patients with encopresis (n=18). Encopresis is the term used to describe involuntary 
fecal soiling, although there is debate among experts on the terminology used to 
describe fecal soiling (Benninga et al, 2005). 
Successful treatment was determined by a physician and was rated and defined 
as ≥ 3 BMs/week and ≤ 1 soiling episode/3 weeks with no abdominal pain (Loening-
Baucke et al, 2004). Parental rating of progress, although subjective, was also assessed 
using a questionnaire. In both fibre treatment arms, stool frequency, stool consistency 
and soiling episodes showed statistical improvement (Loening-Baucke et al, 2004). 
Parental rating showed an improvement of symptoms in 68% of children while on the 
fibre treatment (Loening-Baucke et al, 2004). 
The second study using a fibre supplement in children was done in 48 
chronically constipated children, as assessed by the Rome II criteria. Study participants 
were randomized to the placebo or the cocoa husk supplement group and analysis was 
performed pre- and post-four week control/treatment period, respectively (Castillejo et 
al, 2006).  The fibre source used for the treatment group was cocoa husk soluble 
powder and it was dissolved in 200 mL of whole milk (Castillejo et al, 2006). 
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Four groups of variables were analyzed by these researchers: 1) anthropometry, 
physical exam, routine lab measurements, 2) total and segmental colonic transit time, 3) 
evaluation of bowel movements and stool consistency with a diary, and 4) subjective 
evaluation from parents regarding efficacy of treatment. They found a trend towards an 
increase in transit time in the cocoa husk group compared to the placebo, as well as a 
significant increase in stool frequency in the treatment group (Castillejo et al, 2006). In 
terms of stool consistency, 42% of the treatment group participants observed hard stools 
at the end of the intervention period, compared to 75% of the placebo participants 
(Castillejo et al, 2006). Parental subjective ratings were also analyzed. A significant 
subjective improvement in stool consistency in the treatment group was observed by 
parents. 
Overall, it appears that increased dietary fibre intake is helpful in the treatment 
of many cases of pediatric constipation. There also may be a role for dietary fibre in the 
prevention of constipation, as indicated by the relationship between low dietary fibre 
intakes and increased risk of constipation, but further research is required to confirm 
these findings. 
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CHAPTER 3 
RESEARCH METHODS 
 
3.1  STUDY DESIGN 
 3.1.1 Participants 
 Eligible participants were between the ages of two and ten years and were 
identified by their parents as having a history of constipation and/or a history of 
abdominal pain in the previous twelve months. Organic causes for either condition were 
ruled out prior to study participation. A letter was sent to the participants’ physicians 
indicating their study participation. Participants on a previously established regimen of 
laxatives were permitted to participate in the study and were requested to maintain a 
consistent dose of the laxatives throughout the study period. A detailed questionnaire at 
study start included information on medication and supplement use. 
Participants who experienced encopresis in the previous month, with a history of 
milk allergy, intolerance or sensitivity, with a history of allergy to peas, with celiac 
disease, or who required an enema to resolve fecal impaction one week or less prior to 
the start of the study were excluded. Furthermore, participants diagnosed with 
constipation of organic origin (e.g. Hirschsprung disease, mental deficiency, 
neurological abnormalities, chronic debilitating disease, psychiatric illness, previous 
intestinal surgery), participants with a metabolic disease (e.g. renal insufficiency, 
hypocalcemia, hyperkalemia) and those using medications that affect gastrointestinal 
58 
 
 
motility (e.g. anticonvulsants, imipramine) were excluded from the study. Patients were 
healthy, other than issues with constipation. 
 Approval for the study was granted by the Biomedical Research Ethics Board at 
the University of Saskatchewan, Saskatoon, Saskatchewan (Appendix 1). Informed 
consent was obtained by the caregiver (Appendix 2.1) and assent was sought from 
children seven to ten years of age (Appendix 2.2).  
 
 3.1.2 Recruitment 
 Participant recruitment consisted of children two to ten years of age with a 
history of constipation in the previous twelve months. Constipation was defined 
according to the Canadian Pediatric Society criteria, “Bowel movements that happen 
less often than usual, are hard and dry, and/or are difficult or painful to pass”. Parents 
identified their child as having constipation based on this statement. Participants were 
recruited through advertisements in a local community newspaper (Appendix 3.1) and 
posters displayed at local daycare centres (Appendix 3.2). Posters were displayed from 
May-August 2007 and newspaper ads were placed in August 2007, October 2007 and 
January 2008. Participants were enrolled and completed the study between October 
2007 and May 2008. 
 Interested parents had the option of calling or sending an email to the 
investigator for more information. A copy of the study consent form and a brief written 
explanation was either mailed or emailed to all parents who contacted the investigator. 
The parents of twenty-six children received information about the study either verbally 
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over the phone and/or in written form (mail or email). Of these, seventeen participants 
were enrolled in the study. 
  
3.1.3 Random Assignment  
 The trial was designed as a randomized, double-blind, placebo-controlled, cross-
over study. Eligible participants began with either the placebo or fibre treatment period 
as determined by a computer-generated randomization list, which was controlled by an 
undergraduate student in the College of Pharmacy and Nutrition, University of 
Saskatchewan. Each sequence was a total of three weeks and was not revealed to the 
researchers, the participants or the caregivers until all participants had completed the 
study protocol. 
  
3.1.4 Study Protocol 
Participants and caregivers were advised of the study protocol at the start of the 
study. The participant and caregiver were provided with a three-week supply of the 
supplement and snack foods coded as A or B, depending on their allocated sequence. 
Following unblinding, it was determined that the “A” snacks and supplements were the 
fibre treatment, whereas the items labeled “B” were placebo.  
Participants were requested to consume one package of inulin supplement (5 g 
per day: Fruitafit® CLR, Sensus America LLC, Monmouth Junction, NJ, USA) or 
placebo (5 g of non-resistant maltodextrin: Casco, Globe Plus 18 DE – Maltodextrin, 
Etobicoke, ON, Canada). The supplement was to be mixed with a beverage. They 
would also consume two servings of the study snacks, with or without added pea hull 
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fibre (1.8-3.4 g of fibre per serving: Best Pea Fibre, Best Cooking Pulses, Inc., Portage 
la Prairie, MB, Canada) on a daily basis. At the three-week visit, participants were 
crossed over to the other treatment period. All leftover snacks and packages of 
supplement were returned at that time.  
The snack foods were created and developed by a Product Development 
Specialist (College of Agriculture and Bioresources, University of Saskatchewan) and 
Research Assistant (College of Pharmacy and Nutrition, University of Saskatchewan). 
The recipes were prepared by the same technician (Research Assistant, College of 
Pharmacy and Nutrition, University of Saskatchewan) for all snack foods. 
The placebo recipes did not contain added pea hull fibre (see Appendix 4.1). 
The fibre-supplemented recipes contained pea hull fibre in addition to the other 
ingredients (see Appendix 4.2). In some recipes, including the Chocolate Chip Cookies, 
the Raisin Honey Chews, the Cheese Sticks, and the Honey Graham Crackers, the pea 
hull fibre substituted for part of the wheat flour. Questionnaires were administered to 
caregivers to evaluate the eligibility of the child (Appendix 5.1). Mid-point and post-
study questionnaires were also administered to capture the global assessments of 
caregivers as to whether they perceived that their child was doing better in the first or 
second treatment period (Appendix 5.2 and 5.3).  
Participants and their caregivers had the opportunity to examine the information 
outlining the trial, as well as the consent information. Assent was sought for children 
seven years of age and up, as well as consent from the caregivers of all children. Once a 
consent form was signed, the researcher randomized the participants to begin with the 
“A” or “B” sequence (fibre treatment or placebo). Participants were permitted to taste-
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test the study snacks to determine their preference. Participants were provided with a 
study diary (Appendix 5) and appropriately labeled test foods and supplements.  
Healthy eating, physical activity and adequate fluid guidelines were discussed 
with all caregivers at the study start and Eating Well with Canada’s Food Guide was 
provided as a resource. The participants were weighed and measured at the first visit 
and subsequently at the three-week and six-week visits. 
Participants and/or caregivers were required to keep a record in the study diary 
of the supplement and snacks consumed daily. They were also requested to record the 
number of bowel movements, the presence or absence of abdominal pain, and the 
consistency and appearance of the stool (Bristol Stool Form Scale). This scale has been 
validated as an indicator for intestinal transit time in healthy adults (Lewis & Heaton, 
1997). Caregivers were also requested to record food intake for three days for each 
three-week study period (total of six days per participant).  
The Bristol Stool Form Rating scale is based on a seven-point picture and word 
description of stools (Table 3.1). It has been used in research as an indicator of transit 
time. 
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Table 3.1  Description of Bristol Stool Rating Scale 
Rating Description Transit Rate 
1 Separate hard lumps like nuts Extremely slow 
2 Sausage shaped but lumpy Very slow 
3 Like a sausage but with cracks on surface Normal 
4 Like a sausage Normal 
5 Soft blobs with clear-cut edges Fast 
6 Fluffy pieces with ragged edges Very fast 
7 Watery Extremely fast 
Adapted from Lewis & Heaton, 1997. 
Compliance to the study protocol and acceptability of the snack foods and fibre 
supplement were evaluated using the study diaries. Also, families were requested to 
return unused portions of food and supplement to help determine the accuracy of 
reported intakes.  
Ingredient lists of the high-fibre foods used in the study were provided to all 
participants and their families following the conclusion of the study. Sample packages 
of both inulin and pea hull fibre, as well as the method of preparation of study snacks, 
was provided to all interested families. This allowed them to continue with treatment if 
they deemed it beneficial, although no follow-up was planned or carried out as to 
whether they continued to use the products.  
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3.2  DATA ANALYSIS 
 3.2.1 Sample Size Calculation 
 In a similar cross-over design study, clinical investigators suggested a sample 
size of twenty-six participants. This was based on ά = 0.05 (two-tailed test) and a power 
of 95% to detect a difference of 0.7 compared to 0.2 in attaining normal bowel 
movements in a cross-over design (Loening-Baucke, Miele, & Staiano, 2004). 
However, it should be noted that the current study used a different method of collecting 
data on stool frequency. 
  
3.2.2 Statistical Analysis 
 All statistical analyses were performed using Microsoft Office Excel 2007 ®. 
The differences between the placebo and fibre treatment periods were analyzed for the 
study participants with the paired t-test, also called the repeated measures t-test, which 
is a within subject comparison of pre- and post-test scores. 
A p-value of <0.05 (two-sided) was deemed to be statistically significant. To 
check for period effects, an independent t-test was used. Also, analysis of a possible 
effect of period order was examined using the independent t-test. Due to the stool 
frequency results following a normal distribution, parametric tests were applied to 
analyze the data. Also, in cross-over designs parametric analysis may be the preference 
(Senn, 2002). 
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3.2.3 Demographic Data 
 Demographic information for both the placebo and fibre groups was calculated 
as mean values with a range following randomization. Comparisons between groups 
were made with the independent t-test. 
  
3.2.4 Questionnaires 
 The mid-point and post-study questionnaires included responses graded on a 
five-point Likert scale. Each response ranked between one (indicating an improvement) 
to five (indicating worsening). The response category, “A lot better” represented a score 
of one, “A little better” represented a score of two, “About the same” represented a 
score of three, “A little worse” represented a score of four, and a score of five was 
assigned to the response, “A lot worse”.  
  
3.2.5 Study Diary and Food Records 
 Stool frequency (number per 24-hour period) and abdominal pain (presence or 
absence) were labeled and entered into a spreadsheet. Stool frequency was compared 
between the fibre period and placebo period for all participants for weeks 2 and 3 
separately and combined. The number of incidents of abdominal pain for each 
participant during each study period was compared. Differences for both measures were 
analyzed with the paired t-test. 
 Energy and dietary fibre intakes were analyzed to determine differences between 
the two study periods. The results were analyzed using The Food Processor (Food 
Processor for Windows, ESHA Research, Salem, OR, USA) and then final values were 
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entered into a spreadsheet. The nutrient information for inulin, pea hull fibre and 
maltodextrin was not found in the Food Processor database; therefore, the nutritional 
information for each product, as provided by the suppliers, was entered into the 
program.  
Inulin was analyzed based on 1.6 kcal/g and 90 g of dietary fibre per 100 g of 
product. This includes 1.5 kcal/g from the fermentation of inulin in the colon and the 
resulting energy source (SCFA production) based on a review article (Carabin & 
Flamm, 1999) (see section 2.2.4). The remaining energy comes from the digestible 
carbohydrates (fructose, glucose and sucrose). The pea hull fibre was analyzed based on 
0.58 kcal/g, which consists of 89.3 g of dietary fibre per 100 g of product. The energy is 
provided by a small amount of starch contamination of the fibre, as well as small 
amounts of protein and fat. Due to the insolubility of pea hull fiber and a lack of data on 
the energy yielded by pea hull fibre fermentation in the literature, current labeling does 
not include an energy value from dietary fibre. As a result, any potential energy yield 
from pea hull fibre fermentation could not be estimated in this study and a value of    
0 kcal/g was assigned. Maltodextrin was analyzed based on 3.8 kcal/g of product as it 
did not contain any dietary fibre. 
 Intake of snacks was recorded in the study diary and this was used to measure 
acceptability/compliance. Snacks recorded as half or more consumed were included in 
the analysis. If a snack was recorded as 75% consumed, it was counted as one serving. 
Differences in acceptability between participants from one period to the next were 
compared using a paired t-test. 
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 Intake of the supplement (inulin or maltodextrin) was also recorded in the study 
diary as an indicator of compliance. A minimum intake of half of the portion of 
supplement was required for inclusion in the analysis. An indication of 75% 
consumption was recorded as one full serving. Differences in compliance between 
participants from each period were compared using a paired t-test. 
 For both the snacks and the supplement, the treatment and the placebo groups 
were compared using a paired t-test. A non-significant finding indicates no difference 
between groups in terms of compliance. 
 
3.3  OUTCOMES 
The measures recorded included frequency of bowel movements, presence or 
absence of abdominal pain, dietary fibre intake (three-day food record for each period 
of study, consisting of two, non-consecutive weekdays and one weekend day), 
medications, supplements, stool frequency, stool form rating and anthropometry (body 
weight and height). The outcomes assessed included dietary fibre intake, stool 
frequency, presence or absence of abdominal pain, and changes in energy intake and in 
weight. The Bristol Stool Form Scale was used as a guide for estimating the intestinal 
transit rate (Lewis & Heaton, 1997). 
 The tolerance of the fibre supplement, inulin, and the snack foods fortified with 
pea hull fibre were evaluated by reports from parents and children on any side effects, 
for example, abdominal pain, bloating or gas. The efficacy of the fibre supplementation 
and fortification was evaluated based on changes in stool frequency, transit time and 
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abdominal pain in the last two weeks of each three-week treatment period, using the 
diary in addition to information from the participants and parents. 
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CHAPTER 4 
RESULTS 
 
4.1  STUDY PARTICIPANTS 
4.1.1 Characteristics of Participants 
 Between October 2007 and May 2008, seventeen participants eligible to 
participate in the study were enrolled. Consent was obtained from the parents of all 
participants. Assent was obtained from children ≥ seven years of age (n=4). Thirteen 
participants completed both the placebo and treatment periods (see Figure 4.1 for a 
schematic of the participant flow in the study). The reasons for dropping out included 
the following: one participant moved, one became ill, one participant had a family crisis 
and one child associated the placebo (maltodextrin) with abdominal pain. Three of these 
children were randomized to receive the placebo first and one was randomized to 
receive fibre first. Data from these four children were excluded from the analysis. Data 
analysis included thirteen children with chronic constipation. These eight girls and five 
boys were 3.2-9.6 years old (mean: 5.6 ± 2.2 years). The characteristics of the study 
participants can be found in Table 4.1. 
 
 
Figure 4.1  Participant Flow Diagram 
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Table 4.1  Characteristics of Pediatric Study Participants by Group* 
Case No. Age Gender Laxatives Daily dosage 
Group A 
2 7.9 M None n/a 
4 3.7 F Lactulose 2 tbsp 
5 3.8 F None n/a 
7 5.6 F None n/a 
8 5.1 F None n/a 
10 3.5 M Milk of magnesia 1.5-2 tsp 
11 8.9 F  None n/a 
 
Group B 
1 7 M Magnolax 1 tbsp 
3 3.4 F Lactulose 1-2 tsp 
6 9.6 F None n/a 
9 3.2 M None n/a 
12 6.8 F None n/a 
13 4.1 M Magnolax; milk of magnesia 10 mL; 5 mL 
*Group A refers to participants randomized to fibre/placebo sequence and Group B 
refers to participants randomized to the placebo/fibre sequence. 
 
 4.1.2 Laxative Use 
 Thirty-six percent (five of thirteen) participants were on laxatives but still 
experienced symptoms of constipation. Two participants (Cases 3 and 4) were on 
lactulose, which is a poorly absorbed disaccharide considered to be an osmotic laxative. 
Two additional participants were on milk of magnesia (Cases 10 and 13), although one 
of these (Case 13) and another participant (Case 1) were also on Magnolax. Milk of 
magnesia is a suspension of magnesium hydroxide, whereas Magnolax is in tablet form. 
Both are classified as saline osmotic laxatives.   
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4.2  TOLERANCE 
 There were no reports of significant side effects during the three-week placebo 
and three-week fibre treatment periods. One participant appeared to associate the 
maltodextrin supplement with abdominal pain and discontinued the study as a result.  
 One parent noted an increase in flatulence in her child during participation in the 
fibre treatment period (Case 3). However, it was indicated in the questionnaire that this 
did not appear to cause the child any discomfort or distress. This participant’s intake of 
inulin supplement was measured at 85% over the three-week period and intake of study 
snacks was virtually nil. 
 
4.3  STOOL FREQUENCY 
 4.3.1 Mean Daily Stool Frequency 
 One participant did not record stool frequency for week two of the placebo 
period and week three of the treatment period. An additional participant did not record 
bowel movements during week two of the treatment period. Seven of eleven 
participants on fibre supplements had a significant increase in stool frequency compared 
to the placebo during week two of the study (mean = 0.74 ± 0.27 bowel movements per 
day vs. 0.53 ± 0.21, p = 0.009). Three participants reported no difference and one 
participant experienced decreased stool frequency during the fibre treatment period 
compared to the placebo. There was no significant difference (n = 11) during week 
three of the study between the treatment (mean = 0.64 ± 0.16) and the placebo groups 
(mean = 0.65 ± 0.35) (p = 0.909).  
 In examining weeks 2 and 3 combined, there was a trend towards an increased 
number of daily bowel movements during the treatment period compared to the 
placebo, but this did not reach significance (0.59 ± 0.26 vs. 0.68 ± 0.18, p = 0.064) (see 
Figure 4.2). Case 13 reportedly had diarrhea-type stools (see section 4.5). If this 
participant is excluded from the analysis of stool frequency on this basis, then the trend 
becomes significant (n=10, 0.54 ± 0.18 vs. 0.67 ± 0.22, p=0.002).  
 
Figure 4.2  Comparison of Mean Bowel Frequency for Weeks 2 and 3 Combined 
 
p=0.064 
 Of those parents perceiving a change in stool frequency in their child, four of 
eleven perceived a decrease in stool frequency during the placebo compared to three of 
eleven during the fibre treatment period. 
 
4.3.2 Weekly Stool Frequency 
 Stool frequency by week was also examined. None of the participants 
consistently had fewer than three bowel movements per week throughout the placebo 
period, which is one of the criteria for the diagnosis of pediatric constipation according 
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to the Rome III criteria. One participant (Case 10) had two consecutive weeks of two 
BMs per week during the placebo period but the Rome III criteria require at least a two-
month duration of symptoms with an additional criterion consistently met weekly 
(Hyman et al, 2006). On this basis, none of the participants would meet the Rome III 
criteria unless they fulfilled one of the other criteria, which could not be investigated in 
this study, for example, the presence of a large fecal mass in the rectum. 
 
4.4  ABDOMINAL PAIN 
 Nine of thirteen participants experienced abdominal pain during the study. There 
was no significant difference in the mean number of reported incidents of abdominal 
pain between the fibre treatment period (mean = 5.3 ± 3.4 incidents) and the placebo 
period (mean = 3.6 ± 2.5 incidents) (p = 0.129). 
 Some parents reported abdominal pain as a symptom (six of thirteen) during the 
study. Of those participants experiencing abdominal pain, four of six identified 
increased abdominal pain during the placebo, compared to two of six during the fibre 
treatment period, but this difference did not reach significance (p = 0.490). 
 
4.5  STOOL FORM RATING SCALE 
 A rating of three to four is considered normal transit time based on the Bristol 
Stool Form Rating Scale (Lewis & Heaton, 1997). No significant difference in transit 
time was found between the study periods (p = 0.379). The average rating during the 
fibre treatment period was 3.6 ± 0.9 and during the placebo period it was 3.4 ± 0.9, 
which was within the normal range of 3.0-4.0 (Figure 4.3). The majority of participants 
had a normal transit time during the placebo period with the exception of Cases 6, 11 
and 12. 
 One participant (Case 13) recorded ratings of 5.6 and 5.8 for the fibre treatment 
and placebo periods, respectively, which is actually considered to be rapid transit time, 
more in keeping with diarrhea-type stools. Exclusion of this participant from the 
analysis did produce a significant difference between the two groups (p = 0.002). 
 
Figure 4.3  Comparison of Stool Form Rating Scale For Placebo and Treatment 
Periods 
  
Normal  
Transit 
Time 
p=0.379 
 
 The study periods were also analyzed with the exclusion of the participants on 
laxatives. In this subgroup, no significant differences were found in the estimated transit 
time from one study period to the other (Figure 4.4). The mean stool form rating during 
the treatment period was 3.5 ± 0.7, whereas it was 3.0 ± 0.5 during the placebo period 
(p = 0.115).  
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Figure 4.4  Comparison of Stool Form Rating Scale in a Subgroup of Participants 
Not on Concomitant Laxatives 
 
p=0.115 
 
4.6  PARENTAL PERCEPTIONS  
 4.6.1 Physical Changes 
 Some parents (four of thirteen) identified changes in how their child felt 
physically during the study. Three of those four reported a perceived improvement in 
how their child felt physically during the fibre treatment period compared to the placebo 
period. 
 
 4.6.2 Emotional and Social Changes 
 Only two participants experienced emotional changes, as identified by their 
parents. In both cases, an improvement was identified by parents during the fibre 
treatment period compared to the placebo. One participant was reported to have an 
improvement in social interactions during the fibre treatment period. 
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4.7  COMPLIANCE 
 4.7.1 Snack Foods 
 Compliance with the study snacks was the same for both the placebo and the 
fibre-fortified snacks (74% compared to 77%, respectively, n = 12, p = 0.328). One 
participant (Case 9) consumed virtually no snacks throughout both study periods and so 
was excluded from this analysis. The mean intake of snacks during the placebo period 
was 1.6 snacks per day and 1.7 snacks per day during the treatment period (n = 12; 
range of 0-3 snacks per day).  
 
 4.7.2 Supplement    
 The supplement was consumed equally as often in both periods of the study (p = 
0.412) with a compliance of 91% for inulin and 94% for maltodextrin. Furthermore, 
there were no differences in consumption when participants were compared from one 
study period to the other (sequence 1: fibre/placebo: p = 0.176; sequence 2: 
placebo/fibre: p = 0.983).  
 
4.8  FOOD RECORD ANALYSIS 
 4.8.1 Energy Intake 
 Energy intake was different for the placebo period compared to the fibre 
treatment period for all three days recorded (see Figure 4.5). One participant (Case 2) 
was excluded from the analysis due to missing data (food intake for one of three days 
during the fibre treatment period was not recorded). The mean intake of energy during 
the treatment period was significantly lower at 1307 ± 296 kcal/d, compared to the 
placebo period with a mean intake of 1441 ± 285 kcal/d (n = 12, p = 0.035).  
 
Figure 4.5  Comparison of Energy Intake During Fibre Treatment and Placebo 
Based on Three-Day Food Records 
  
p<0.05 
 
 4.8.2 Dietary Fibre Intake 
 As revealed by the food records, the mean dietary fibre intake for the treatment 
period was significantly higher than the dietary fibre intake during the placebo period 
(see Figure 4.6) (n = 12, 17.1 ± 2.5 g/d vs. 11.1 ± 2.6 g/d, p<0.001). During the placebo 
period, the snacks provided a mean of 1.0 ± 0.8 g/d of dietary fibre compared to 3.7 ± 
1.2 g/d during the fibre treatment period (p<0.001). The fibre treatment group 
consumed an average of 4.2 ± 0.9 g/d from inulin, whereas maltodextrin did not provide 
any fibre during the placebo period as it is not considered to be a source of dietary fibre. 
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Figure 4.6  Comparison of Dietary Fibre Intake by Study Participant and Period 
Based on Three-Day Food Records 
  
p<0.001 
 
  
There was no significant difference in the amount of dietary fibre provided to 
participants by the rest of the diet. The placebo group consumed 9.8 ± 2.6 g/d compared 
to 9.4 ± 2.1 g/d (p = 0.584) for the treatment group exclusive of the fibre provided by 
the pea fibre and inulin. Table 4.2 below provides a comparison of usual intakes of 
dietary fibre for Canadian children compared to the study participants. In the current 
study, children 1-3 years old had similar intakes compared to the survey data obtained 
for Canadian children. However, the older children 4-10 years in the current study had a 
trend towards lower mean dietary fibre intakes when compared with the survey data.  
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Table 4.2  Dietary Fibre Intakes (g/d) of Canadian Children* Compared With 
Study Participants by Age Group 
Age 
(years) 
   n*                  Mean 2004 Data* n                         Mean Study Data 
                           (Placebo Period) 
1-3 2117                      10.2 5                             10.0                   
4-8 3235                      13.5 5                             12.1 
9-13 
(female) 
1980                      14.4 2                             12.2 
*Statistics Canada, Canadian Community Health Survey, Cycle 2.2, Nutrition (2004) – 
Share File 
  
When fibre intakes were examined on a per 1000 kcal of energy basis, the fibre 
treatment group had a significantly greater intake (mean intake = 13.2 ± 2.9 g/1000 
kcal) than did the placebo group (mean intake = 9.5 ± 3.6 g/1000 kcal, p<0.001). The 
fibre treatment group neared the recommended AI for dietary fibre of 14 g/1000 kcal 
(indicated by the red line in Figure 4.7).  
 
Figure 4.7  Comparison of Dietary Fibre Intake per 1000 kcal of Energy Intake 
For the Treatment and Placebo Groups 
 
p <0.001 
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As the recommendation for dietary fibre is set as an AI, it can be viewed in 
terms of mean intakes. Four participants (Cases 3, 4, 11 and 13) had a mean intake of 
≥14 g of dietary fibre per1000 kcal of energy intake during the treatment period. Three 
of the four participants had intakes at this level during the placebo period as well, 
although the intakes were at least two grams per day higher during the fibre treatment 
period for all four participants based on the data from the three-day food records. 
 
4.9  ANTHROPOMETRIC DATA 
 The study participants had their weight and height measured at the study start, 
mid-point (cross-over) and end of the study (see Table 4.3). Data for one participant 
were missing (Case 2- measurements not taken at mid-point of study). The BMI (body 
mass index) for each participant at each time point was measured using the standard 
equation of BMI = weight (kg)/height (m)². The BMI values were then plotted on the 
2000 CDC (Centres for Disease Control) Growth Charts. The differences in BMI 
following the fibre treatment and placebo periods were compared for each participant. 
For example, the weight and height of a participant who started on the fibre treatment 
were taken at baseline and after three weeks. The difference in BMI between the 
baseline and mid-point of the study was then calculated. For the placebo period, the 
change in BMI from the mid-point to end of the study would be calculated for this 
participant. In this manner, the changes in BMI for each participant were compared for 
each period of the study to determine if there were significant differences between 
them. This would help to indicate whether participants potentially gained more weight 
compared to height while on the placebo treatment compared to the fibre treatment. 
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Table 4.3  BMI Data for Study Participants 
Case 
No. 
BMI #1 BMI #2 BMI #3 Difference during 
Fibre Treatment 
Difference during 
Placebo Period 
1 19.5 20.7 20.6 0.1 1.0 
3 16.2 16.7 16.4 -0.3 0.9 
4 16.8 16.8 16.4 0.4 -0.4 
5 15.9 16.6 16.5 0.6 -0.3 
6 28.4 28.1 27.7 -0.3 0.1 
7 14.7 14.4 14.6 -0.2 0.3 
8 18.1 17.8 18.2 -0.4 0.4 
9 16.1 16.1 15.8 -0.3 -0.2 
10 16.9 16.9 16.6 0.3 -0.3 
11 18.1 18.0 18.5 -0.1 0.6 
12 13.9 13.9 14.3 0.7 -0.2 
13 16.1 16.5 16.4 -0.1 0.8 
 
Based on the article “The Use and Interpretation of the CDC Growth Charts” 
(2000), the BMI for all participants was within the normal range (5th-85th percentile) 
with the exception of three (Cases 1, 6 and 10). The ages of these participants were 7, 9 
and 3, respectively, and Cases 1 and 10 were male, whereas Case 6 was female. All 
three of these participants had a BMI ≥95th percentile, which places them in the 
overweight category based on the nutritional risk indicator (CDC, 2000). None of the 
participants was classified as underweight. Additionally, it was found that there were no 
significant differences in the change in BMI between participants for the fibre and 
placebo periods (n = 12, mean = 0.04 and 0.23, respectively, p = 0.399). 
Due to growth in children, changes in weight and height would be expected. 
However, in the short time frame of this study, it would not be expected that any 
significant changes in BMI would occur, as children tend to grow proportionately in 
height and weight. Also, the BMI of boys and girls appears to be lower in children 
under the age of ten compared to adolescents. 
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4.10 PERIOD EFFECT 
 All major parameters were analyzed to determine if there was a period effect, 
that is, whether or not there was a difference in the findings for participants who started 
on the  placebo treatment versus those who started on the fibre treatment. Given that 
random allocation was used, it would not be expected that a period effect would be 
found (Senn, 2002). This was true in this study for the following: stool frequency, stool 
consistency, dietary fibre and energy intake, and compliance, as all of these resulted in 
non-significance using the independent t-test. 
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CHAPTER 5 
DISCUSSION 
 
 
5.1  DISCUSSION 
 This study demonstrated that dietary fibre fortification and supplementation can 
significantly increase the overall dietary fibre intake of children. Inulin supplementation 
was an acceptable method of adding dietary fibre to beverages, and fortification with 
pea hull fibre was an acceptable method of adding dietary fibre to snack foods. The 
addition of fibre to snack foods and beverages may provide a means to reduce their 
energy density. Finally, an increase in dietary fibre intake in children with mild 
constipation may not increase stool frequency and normalize intestinal transit time, 
particularly if stool patterns are within the normal range prior to increased dietary fibre 
intake. 
Because of a lack of data, the Dietary Reference Intake for dietary fibre is set as 
an Adequate Intake (AI) based on intake levels estimated to be adequate in healthy 
people. In the case of dietary fibre, it is based on the observed amount shown to be 
protective against coronary heart disease (Slavin, 2004). It is not known what level of 
intake is required to promote adequate laxation. 
The intake of dietary fibre for most children falls short of recommendations. The 
nutrient intakes of Canadian children were assessed in 2004 through the Canadian 
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Community Health Survey. It was found that 1-3 year old children (n = 2117) 
consumed a mean of 10.2 g/day of dietary fibre, whereas 4-8 year old children (n = 
3235) consumed a mean of 13.5 g/day (Health Canada, 2006). This is a similar level of 
intake to the study group during the placebo period (11.1 g/day). The AIs for the age 
groups mentioned are 19 and 25 g/d, respectively. However, current data do not include 
functional fibre sources. Also, it is unknown how much functional fibre an average diet 
contains, although estimates for inulin and oligofructose in the U.S. are in the range of 
1-4 g/day compared to 3-11 g/day for Europeans (Van Loo, 1995). Data from the CSFII 
(1994-1996) in the U.S. indicate an average intake of 2.6 g/day for inulin and 2.5 g/day 
for oligofructose (Moshfegh, Friday, Golman, & Chug Ahuja, 1999). Inulin has been 
added to many foods in Europe and North America over the last decade, and it has 
become widely available as a fibre supplement. It would be expected that these intakes 
have increased substantially but this data is not yet available. 
The acceptance of the inulin supplement was particularly good among the 
participants. In most cases, it was dissolved in milk, chocolate milk or apple juice. In a 
few cases, when parents did not blind the child to supplementation of her beverage, she 
had a higher tendency to say she did not like it. The intake of snack foods was less than 
that of the inulin supplement. However, two servings of the snack foods were required 
daily compared to one serving of the inulin supplement. Other reasons for the decreased 
intake of snacks may have been related to the smaller selection of choices relative to 
what participants were accustomed to, or the replacement of usual, favourite snacks 
with study snacks. There were no stated concerns with the flavour of either the placebo 
or fibre-fortified snacks. This might be due to the fact that it was not necessary to 
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“blind” the child to the addition of the fibre or placebo into the food/beverage and may 
point to an advantage of having fibre-containing food and beverages on the market. 
 The epidemiological evidence for the prevention of obesity through higher 
dietary fibre intakes is reportedly strong (Slavin, 2004). There is a known gap between 
actual intakes of dietary fibre in children and the recommended amounts (Kranz et al, 
2005).  The current study found that energy intakes were significantly lower during the 
fibre treatment period of the study as compared to the placebo or “regular diet” period. 
This may occur through the “displacement” of energy dense ingredients such as sugar 
and fats, which may provide another potential application for the addition of fibre 
sources such as pea hull fibre and inulin to snack foods and beverages.  
It should be noted that the fermentation of the fibre sources in question may 
have yielded additional energy. This is due to the fact that the SCFAs produced by 
fermentation are absorbed by colonocytes as an energy source with an estimated yield 
of 1.5 -2.5 kcal/g (Otten et al, 2006). On the other hand, it is thought that SCFAs have a 
direct effect on the regulation of satiety, thereby decreasing overall energy intake 
(Pereira & Ludwig, 2001). This may result in a negative energy balance if overall intake 
decreases compared to non-fermented carbohydrate sources. Energy provided by inulin 
fermentation was included in the analysis (1.5 kcal/g); however, it was not for pea hull 
fibre, as no data is available on the energy yield of pea hull fibre fermentation. 
 The results of this intervention are unique as this is the first time that two 
sources of dietary fibre have been used concurrently to increase dietary fibre intake in 
constipated children. Studies in adults have been completed with each type of fibre. One 
study using finely processed pea hull fibre (mean dietary fibre fortification = 3.1 g/d) 
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added to usual foods in a population of elderly patients found a significant increase in 
stool frequency (n = 114, 18.7 ± 9.4 BMs/month at baseline versus 20.1 ± 9.6 
BMs/month during the fibre treatment, p<0.05) (Dahl et al, 2003). Interestingly, this 
study found an even larger difference in the sub-group of patients who had the lowest 
frequency of bowel movements (n = 17, 8.8 ± 1.0 BMs per month at baseline compared 
to 12.6 ± 3.8 BMs/month during the fibre treatment) (Dahl et al, 2003). The current 
study is particularly interesting in light of the lack of significant differences in stool 
frequency between the placebo and the fibre treatment groups, despite the significant 
increase in dietary fibre consumed.  
 The Rome III criteria for the diagnosis of pediatric functional constipation 
require as part of the diagnosis a bowel frequency of less than three BMs per week. It is 
interesting to note that none of the study participants consistently reported two or fewer 
weekly bowel movements during the placebo period of the study. Although parental 
perception indicated the participants were constipated, it is possible that their symptoms 
would not be deemed clinically significant with the use of a more strict definition such 
as Rome III. In this study, the other criteria associated with Rome III were not 
examined so it is unknown whether these participants would have fulfilled any of the 
other criteria, thereby meeting the diagnostic criteria for functional constipation. Further 
to this, the use of such a definition would possibly have provided a more homogeneous 
group of participants but would have required the participation of a closely involved 
physician. These children appear to have had normal transit time based on the Bristol 
Stool Form Scale, which would further put into question whether or not all study 
participants were in fact constipated. 
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 Dietary fibre sources vary greatly and each type has its own physiological 
effects, which are not always studied in great detail. Prebiotics such as inulin have been 
studied more extensively than some other sources of fibre. In Canada, for example, a 
so-called “novel source” of fibre, such as pea hull fibre, must be proven to be safe and 
to have a physiological effect in order for it to be permitted for use as an ingredient in 
food (CFIA, 1996). Both pea hull fibre and inulin have been approved for such use. 
Intervention studies have shown that inulin increases stool weight and thereby 
increases stool frequency, and the range of dosages used in research have varied from 5-
15 g/day (Roberfroid, 2002). The daily inulin dose in this study (5 g weight = 4.5 g of 
fibre) was at the lower end of this scale due to the additive effect of using two fibre 
sources. As the inulin and pea hull fibre were well tolerated by the study participants, an 
increased intake of inulin may have produced a more significant effect on stool patterns. 
Stool output was not tracked in this study, although fecal bulking capacity of the 
inulin supplement and pea fibre fortified snack foods can be estimated using previous 
research. Bulking index has been used to compare the variable bulking capacities of 
indigestible carbohydrates in rat and human studies. The bulking index is measured as 
either an increase in fecal wet or dry weight in grams per gram of added indigestible 
carbohydrate in the diet (Nyman, 2002). For inulin, studies in humans have 
demonstrated a bulking index of 1.5 (based on fecal dry weight) (Den Hond, 2000; 
Nyman, 2002). In the current study, 4.5 g of dietary fibre from inulin were to be 
consumed daily; multiplied by the bulking index of 1.5, this would result in a bulking 
capacity of 6.75 g per day.  
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Only rat studies are available for estimation of the bulking capacity of pea fibre 
and results should, therefore, be interpreted with caution. A bulking index of 0.2 g 
(based on fecal wet weight) was calculated by Hansen, Bach Knudsen, & Eggum 
(1992), but the pea fibre in their study was obtained from cotyledon cell wall fibre 
rather than hull fibre, which would have different characteristics. 
 The diet was not controlled in this study and this may account for the lack of a 
significant effect on stool frequency of the fibre sources used, namely inulin and pea 
hull fibre. For example, one parent stated that for their young child, the study snacks 
were sometimes so filling that their child’s fruit intake was affected. In the case of 
young children, it may be that fibre added to a beverage, rather than provided as a snack 
food, would have less impact on overall intake of plant-based foods. Plant-based foods 
such as fruits, vegetables and whole grains are recognized as containing many other 
beneficial nutrients in addition to dietary fibre.  
 Although some of the study participants were using concomitant laxatives, it 
does not appear likely that these impacted the results to any great degree, as they had 
been on this treatment for some time and were requested to maintain the same therapy 
throughout the study period. Also, for parameters such as stool frequency and transit 
time measured in this study, secondary analysis of the data with exclusion of 
participants on laxatives did not result in significant findings.  
The laxative lactulose has a similar physiological effect as does dietary fibre, as 
it is a poorly absorbed disaccharide that is rapidly fermented in the large intestine. 
Although it is not currently classified as a dietary (functional) fibre, one study included 
6 g lactulose in comparison with 20 g of pectin or cellulose in a study protocol 
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examining differences in fermentation in men (Chinda et al, 2004). For the two study 
subjects using lactulose, they received a range of 3-20 g of lactulose. This would appear 
to be significant doses, which could mean that the intestinal microflora had reached a 
certain threshold in terms of bifidogenicity and fermentation and that they would not 
have experienced further benefits from the inulin supplementation. 
 An important advantage of the use of dietary fibre supplements and fibre-
fortified foods is that it is viewed by parents as less “medical”, with less chance of their 
child’s bowel becoming used to it, such as with an osmotic laxative like lactulose. Many 
parents try to balance the potential effects of medication by using laxatives only when 
their child is symptomatic, which often results in a cycle of normal bowel movements 
and constipation. This could perhaps be explained by the fact that parents score their 
children worse in terms of quality of life (QOL) than constipated children themselves 
do. Clarke et al (2007) demonstrated that the parents of children with slow transit 
constipation (STC) reported a significantly lower QOL score than did their children. On 
the other hand, parents of controls scored similar QOL scores to their children’s (Clarke 
et al, 2008). This may be related to the fact that there is often a family history of 
constipation and parents may be projecting their own experiences onto their child 
(Clarke et al, 2008). 
There are a few notable limitations in the current study. The small sample size 
indicates that caution must be exercised with the interpretation of results, although 
many fibre studies have small sample sizes of about 10-12 healthy individuals. Also, 
two fibre sources were investigated in this study, which have been studied in adults but 
not in the pediatric population. Due to this it is unclear if the effects occurred as a result 
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of one or the other fibre sources. Further to this, additional measures could be used to 
better assess some of the parameters such as the quality of life of children experiencing 
constipation and analysis of stool weight and bacterial content. In spite of the 
aforementioned limitations, the objectives of the study were met, which provides a basis 
for future research into the effects of these fibre sources on childhood constipation. 
Most researchers would agree that in terms of public health initiatives, 
recommendations should focus on an increased consumption of dietary fibre through 
plant-based foods such as vegetables, fruits and whole grains. It has been shown in 
previous studies that nutrient density and hence the quality of the diet improves with 
increasing dietary fibre intake in children. However, it has also been demonstrated that 
there are numerous barriers to this approach including lack of appetite in constipated 
children, low overall intake of high-fibre foods and lack of appeal of many high-fibre 
snack foods available in the market. For children experiencing constipation, a plant-
based diet in addition to supplements and/or snack foods fortified with fibre may be a 
more effective approach to help them achieve their goal of increasing dietary fibre 
intake. 
 
5.2  CONCLUSION 
 To summarize, this study showed that dietary fibre intake in children can be 
increased by means of fortification and supplementation. Also, it has provided some 
evidence for the reduction of energy in snack foods and beverages by the addition of 
dietary fibre. Finally, inulin and pea hull fibre are well tolerated and accepted means of 
increasing dietary fibre intake in children with constipation. 
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5.3  FUTURE RESEARCH 
 The results of this study are encouraging in that a larger randomized control trial 
would be warranted to examine the effects of fibre supplementation and fortification on 
childhood constipation. The protocol of future studies would be enhanced by the 
provision of the fibre sources separately and in combination to determine the optimal 
treatment, to use defined criteria for the diagnosis of constipation such as the Rome III 
criteria, and to better assess the quality of life issues of these children with a validated 
tool such as the Pediatrics Quality of Life Inventory (PedsQL™). Future research could 
also examine the role of laxatives in combination with the fibre sources for hard-to-treat 
cases of childhood constipation.  
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2.1  Parent/Legal Guardian Information and Consent Form 
 
  
 
Participant Information and Consent Form 
 
 
Study Title:  The Effect of Fibre Fortification on Stool Frequency in Children with a 
History of Constipation 
 
Principal Investigator: Dr. Wendy J. Dahl is investigating the effect of fibre fortification 
on bowel habits of children who have experienced constipation. 
 
Wendy Dahl RD PhD, Adjunct Professor 
College of Pharmacy and Nutrition, University of Saskatchewan 
110 Science Place, Saskatoon, SK, S7N 5C9 
 
Sub-investigator: Carla Flogan RD, Graduate Student, College of Pharmacy and 
Nutrition, University of Saskatchewan 
 
Study Sponsor: Saskatchewan Pulse Growers 
The sponsor of this study, Saskatchewan Pulse Growers, will reimburse Dr. Wendy 
Dahl for the costs of undertaking this study by providing a graduate student stipend 
to Carla Flogan.  However, neither the institution nor any of the investigators or staff 
will receive any direct financial benefit from conducting this study. 
 
Your child is being asked to take part in this research because he/she has had 
constipation in the last 12 months. Participation is voluntary and you have the right to 
refuse your child’s participation in this study. If you decide your child can volunteer, 
you can also withdraw him/her from the study at any time. If you do not wish your child 
to participate, you do not have to provide any reason for your decision, nor will your 
child lose the benefit of any care to which he/she is entitled or is presently receiving. 
Please take the time to read the following information carefully and to discuss it with 
your family, friends, and doctor before you decide. 
 
Please note that children with Type 1 or Type 2 diabetes or food allergies are excluded 
from this study. Inform the researchers if your child has either of these conditions. 
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Purpose of the Study: 
 
The purpose of this study is to determine whether adding fibre to usual foods improves 
the intake of dietary fibre, as well as increasing the number of bowel movements. Some 
children do not consume enough dietary fibre. In many cases, a diet high in dietary fibre 
has been shown to increase the number of bowel movements a child has. 
 
Benefits:  
  
There may not be any direct benefits to your child for participating in this study. Your 
child’s constipation may or may not improve during the study period. Knowledge 
gained from this study may help to improve nutritional care for children who experience 
chronic constipation.  
 
Procedures: 
 
1. Your child will be asked to participate in this study for a period of six weeks. 
This will be made up of two consecutive periods of three weeks. Your child will 
be asked to eat the food provided as part of his/her snacks. During one half of 
the study, the food will contain added fibre and during the other half of the 
study, there will be no fibre added to the food. You will also add a small 
package of white powder containing fibre or a starch (no fibre) to food or 
beverages that your child consumes. Neither you nor the researchers will know 
when your child is consuming the food or powder with fibre. This will be 
achieved by randomly assigning your child to start with either the fibre added or 
no fibre added arm of the study. 
 
2. You will need to meet with the pediatric dietitian (Carla Flogan) to go over the 
study information. At that time, you will be asked to fill out a short 
questionnaire about your child’s history of constipation and any related medical 
diagnoses. You will also be asked to list any medications or supplements that 
your child takes. There will be three visits with the pediatric dietitian at the start 
of the study, at the mid-point (after three weeks) and at the end of the study 
(after six weeks). 
 
3. You will be asked to fill out a three day food record for your child during each 
three-week period of the study (a total of six days of food records) for your 
child. This will need to be two non-consecutive weekdays and one weekend day 
for each study period. 
 
4. Your child will be requested to fill out a daily record of his/her stool habits 
including appearance, frequency and consistency. If your child is unable to fill 
out the study diary, you would be requested to do this on his/her behalf. 
 
5. You will be asked to fill out a short questionnaire at the mid-point (at three 
weeks) and end of the study period (after six weeks). 
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6. Your child will be able to consume his/her regular diet. However, your child 
will need to replace two snack foods every day with foods that will be provided 
to you by the researchers. These foods may or may not contain added fibre. The 
food can be picked up when you meet with the study dietitian. The powder fibre 
or starch can be added to foods or beverages that your child already consumes. 
Any unused portions will be returned to the researchers at the end of each study 
period, again at the visits with the study dietitian. 
 
 
• The white powder packages will contain either inulin (a food fibre) or maltodextrin  
(a food starch). The inulin or maltodextrin will be similar in appearance and will  
contribute very little to the flavour of the food/beverages that they are added to. 
• Your child will be asked to eat two snacks every day such as crackers, cookies, snack  
cakes and granola bars instead of his/her regular snacks or desserts. During half of  
the study, they will have pea fibre added to them. During the other half, they will not 
have added fibre in them. Your child will not know when he/she is eating a regular  
food or a food with added fibre. 
• Please note that some of the snacks contain nuts or have come into contact with nuts.  
This should be kept in mind if your child’s school is nut-free, as they should not be  
sent to school. 
 
It is not expected that changing your child’s snacks will require any additional time. 
Your time commitment for this study is estimated at about 10 hours over the course of 
the study. This includes three interviews of one hour each at the University of 
Saskatchewan at the start, mid-point and end of the study, the time it takes to help your 
child with daily stool records and the two three-day food records that you will do for 
your child. 
 
Confidentiality:  
 
While absolute confidentiality cannot be guaranteed, every effort will be made to ensure 
that the information you provide for this study is kept entirely confidential. Your child’s 
name will not be attached to any information. It will not be mentioned in any study 
report, nor be made available to anyone except the research team. The research team 
may wish to present the results of this study in scientific journals or at conferences and 
workshops, but your identity will not be revealed. 
 
With your permission, we will inform your child’s family physician of your 
participation in this study. This is to help ensure that there is no medical reason, to the 
best of your family physician’s knowledge, your child should not participate in this 
study. 
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Participation is Voluntary: 
 
Your child’s participation in this study is entirely voluntary. You have the right to 
refuse to allow your child to participate and you can withdraw your child from the study 
at any time, for any reason. Early withdrawal from the study will not result in any sort 
of penalty.  
 
Alternative Treatment: 
 
Your child does not have to participate in this study to receive treatment for his/her 
constipation. Your family physician or pediatrician can recommend other treatment 
options, such as medications or behavioural approaches. 
 
 
Potential Risks: 
 
The risk of consuming fibre-fortified food may include symptoms such as gas and 
bloating. 
 
Research Related Injury: 
 
There will be no costs to you for your participation in this study. You will not be 
charged for any research procedures and participating in this study will not affect your 
care. In the event that your child becomes ill or injured as a result of participating in this 
study, medical treatment will be made available at no additional cost to you. 
 
Compensation:  
 
You will be provided with $45 for your participation in this research study. This 
compensation is intended to cover the costs of parking, travel and your time. 
 
Contacts:  
 
If you have any questions with regards to this research project, please do not hesitate to 
contact the researchers below: 
 
Carla Flogan (Moreau)  (306) 933-4535  
Wendy Dahl    (306) 655-1310 
 
This study has been approved, on ethical grounds, by the Biomedical Research Ethics 
Board (Bio-REB) of the University of Saskatchewan. If you have any questions about 
your rights as a research subject, you may contact the chair of the Biomedical Ethics 
Board, c/o the Ethics Office, University of Saskatchewan at (306) 966 4053. 
 
The contents of this consent form have been explained to me. I have been able to ask 
questions about the study and these questions have been answered to my satisfaction. I 
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have received a copy of the consent form for my own records. I freely consent to my 
child’s participation in this study. I am not waiving any of my legal rights by signing 
this consent form.  
 
I consent to a letter being sent to my family physician about my child’s participation in 
this study. 
□ Yes  □ No 
 
 
SIGNATURES 
 
Parent/Legal Guardian: ________________________Date: __________________ 
 
Research Coordinator: ________________________ Date: __________________ 
2.2  Participant Information and Assent Form 
 
 
 
Participant Information and Assent Form  
    
 
Study title: The Effect of Fibre Fortification on Stool Frequency in Children with a 
History of Constipation 
 
You are invited to be a volunteer in this study because you have had constipation in the 
past year. 
 
Taking part in this study is not part of your schoolwork. This study is not part of your 
medical treatment. You do not have to take part in this study. If you decide to take part, 
you can quit at any time for any reason. Quitting the study will not result in any penalty 
or loss of health care services. 
 
If you volunteer for this study, 
 
• You will be asked to add a white powder food fibre or food starch to the foods/drinks 
you eat. During one part of the study, it will have inulin (a food fibre) in it. A food  
fibre is the part of plant foods that we can’t break down in our bodies. During the  
other half of the study, it will have a food starch in it. Food starch is in pasta, bread  
and rice. You will not know if you are eating a food starch or food fibre. 
• You will be asked to eat two snacks every day such as crackers, cookies, snack cakes  
and granola bars instead of your regular snacks or desserts. During half of the study,  
these foods will have the outsides of peas hidden in them. During the other half, they  
will not have added pea fibre in them. You will not know when you are eating a  
regular food or a food with added fibre. 
• You will be asked to write down the snacks you eat, how your tummy feels and to  
describe things about going to the bathroom in a study diary every day. You can  
write this down at the end of each day and you don’t have to take your study diary to 
school. This will take about 5 minutes to do each day.   
 
After eating food with added fibre, you may notice changes when you go to the bathroom.  
You may notice more or less gas and bloating. You may notice changes in your stools.  
You may notice changes in how often you need to pass stools.  
 
Being part of this study will be kept private. No one other than the research people will  
know that you are taking part in this study. No one at your school will be told about the  
study. What you tell the dietitian will also be kept private. She will not use your name to  
tell the other researchers about how you are feeling.   
 
The snacks with pea fibre will be in packaging that might look different than other food  
such as plastic bags. The white powder might look like medicine instead of food. These  
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snacks might have different packaging than the food and drinks other kids take to school. 
 
The information we find out from this study will be used to write a report for a medical  
or nutrition journal. Your name will not be used. 
 
 
If you have any questions about this research project, please call: 
    
Carla Flogan (Moreau)   (306) 933-4535  
Wendy Dahl     (306) 655-1310 
 
 
The information on this form has been explained to me. I have been able to ask 
questions about the study and these questions have been answered in a way that I 
understand. I have a copy of this form for my own records. 
 
SIGNATURES 
 
Study Volunteer: _________________________ Date: __________________ 
 
 
Research Coordinator: _____________________ Date: __________________ 
 
 
Witness: ________________________________ Date: __________________ 
 
APPENDIX 3 
 
Recruitment 
 
 
 
3.1  Newspaper Recruitment Advertisement 
 
 
 
Research Subjects Needed 
 
A study is being conducted at the University of Saskatchewan to see if adding fibre to 
snack foods will help relieve constipation in children. 
We are looking for children who: 
? Are 2-10 years old 
? Have had a history of constipation in the last 12 months 
The time commitment includes 3 visits to the University of Saskatchewan over a period 
of about six weeks. Compensation is provided. For more information, interested parents 
can contact Carla, Nutrition Graduate Student, College of Pharmacy and Nutrition at 
260-5546 or carla.flogan@usask.ca. Please leave your contact information and you will 
receive a response within 1-2 days. The principal investigator for this study is Dr. 
Wendy Dahl, College of Pharmacy and Nutrition. 
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3.2  Recruitment Poster for Daycare Centres 
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APPENDIX 4 
 
Study Recipes 
 
 
 
4.1  Placebo Recipes 
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4.2  Recipes with Pea Fibre  
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APPENDIX 5 
 
Questionnaires 
 
5.1  Pre-Study Questionnaire 
 
 
The Effect of Fibre Fortification on Stool Frequency  
In Children with a History of Constipation 
 
Your Name:____________________Child’s Name:___________________________ 
 
This questionnaire was designed to collect information on the medical history of your 
child that is relevant to his/her participation in this study. There will also be questions 
about the medications and supplements that your child is currently taking. Information 
that you provide will be kept confidential. 
 
1. Has your child experienced constipation in the last 12 months? The Canadian 
Paediatric Society defines constipation as “bowel movements that happen less often 
than usual, are hard and dry, and/or are difficult or painful to pass”. 
? Yes 
? No 
? Not sure 
 
2. Does your child have a known allergy to milk or milk products such as yogurt? 
? Yes 
? No 
? Not sure 
 
3. Does your child have a known allergy to peas? 
? Yes 
? No  
? Not sure 
 
4. Has your child ever been diagnosed with celiac disease? 
? Yes 
? No  
? Not sure 
 
5. Has your child had an enema for constipation in the last week? 
? Yes 
? No 
? Not sure 
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6. Has your child experienced stool leakage in the last month? 
? Yes 
?  No 
? Not sure 
 
7.  Please indicate if your child has been diagnosed with any of the following: 
 
? Hirschsprung disease   
? Neurological abnormality such as seizure disorder 
? Kidney disease 
? Mental deficiency 
? Psychiatric illness 
? Low calcium blood levels 
? High potassium blood levels 
 
8. Has your child ever had surgery on his or her intestines? 
? Yes 
? No 
? Not sure 
 
9. Please list the medications that your child is currently taking and the dosage. 
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________ 
 
 
10. Please list any supplements such as herbal medications, vitamins and minerals that 
your child is currently taking. 
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________ 
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5.2  Cross-Over Questionnaire 
 
 
The Effect of Fibre Fortification on Stool Frequency  
In Children with a History of Constipation 
 
Your Name:____________________Child’s Name:___________________________ 
 
This questionnaire was designed to collect information about how your child is doing at 
this point in the study. The information that you provide will be kept confidential. 
 
 
1. Do you think your child’s stool frequency has changed since the start of the study? 
? Yes 
? No 
? Not sure 
 
If yes, has your child’s stool frequency: 
? Increased 
? Decreased 
 
2. Do you think that your child’s abdominal pain has changed since the start of the 
study? 
? Yes 
? No 
? Not sure 
? Not applicable 
 
If yes, has your child’s abdominal pain: 
? Increased 
? Decreased 
 
3. How often, on average, does your child drink the yogurt or milk drink provided? 
? None 
? Less than one serving per day 
? One serving per day 
? More than one serving per day 
 
4. How often, on average, does your child eat the snack foods provided? 
? None 
? Less than one serving per day 
? One serving per day 
? Two servings per day 
? More than two servings per day 
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5. Have there been any changes in the way your child feels physically since the start of 
the study? He/she is feeling… 
? A lot better 
? A little better 
? About the same 
? A little worse 
? A lot worse 
 
 
6. Have there been any changes in the way your child feels emotionally since the start 
of the study? He/she is feeling… 
? A lot better 
? A little better 
? About the same 
? A little worse 
? A lot worse 
 
7. How has your child been getting along with other children since the start of the 
study? He/she is getting along with other children… 
? A lot better 
? A little better 
? About the same 
? A little worse 
? A lot worse 
 
8. Do you have any comments, questions or concerns about any part of the study to 
date? 
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________ 
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5.3  Post-Study Questionnaire 
 
 
The Effect of Fibre Fortification on Stool Frequency  
In Children with a History of Constipation 
 
Your Name:___________________ Child’s Name:____________________________ 
 
This questionnaire was designed to collect information about how your child is doing 
since the mid-point of the study (about three weeks ago). The information that you 
provide will be kept confidential. 
 
 
1. Do you think your child’s stool frequency has changed since the mid-point of the 
study? 
? Yes 
? No 
? Not sure 
 
If yes, has your child’s stool frequency: 
? Increased 
? Decreased 
 
2. Do you think that your child’s abdominal pain has changed since the mid-point of 
the study? 
? Yes 
? No 
? Not sure 
? Not applicable 
 
If yes, has your child’s abdominal pain: 
? Increased 
? Decreased 
 
3. How often, on average, does your child drink the yogurt or milk drink provided? 
? None 
? Less than one serving per day 
? One serving per day 
? More than one serving per day 
 
4. How often, on average, does your child eat the snack foods provided? 
? None 
? Less than one serving per day 
? One serving per day 
? Two servings per day 
? More than two servings per day 
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5. Have there been any changes in the way your child feels physically since the mid-
point of the study? He/she is feeling… 
? A lot better 
? A little better 
? About the same 
? A little worse 
? A lot worse 
 
 
6. Have there been any changes in the way your child feels emotionally since the mid-
point of the study? He/she is feeling… 
? A lot better 
? A little better 
? About the same 
? A little worse 
? A lot worse 
 
7. How has your child been getting along with other children since the mid-point of the 
study? He/she is getting along with other children… 
? A lot better 
? A little better 
? About the same 
? A little worse 
? A lot worse 
 
8. Do you have any comments, questions or concerns about any part of the study? 
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
APPENDIX 6 
 
Study Materials 
 
 
 
6.1 Study Diary 
My Study Diary
Name _____________
Date        
Put a check (?) in the box if you had these foods/drinks today 
Your goal is to have one yogurt drink plus two other snack foods every day 
Yogurt Drink        
Crackers        
Cookies        
Granola bar        
Puffed wheat cake        
Other        
Stools – describe stools when present 
Frequency 
(# of stools/day) 
       
Description (Rate 1-
7, see back page of 
diary) 
       
Stomach Pain 
0=None,1=a little, 
2=moderate,3=a lot 
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6.2 Stool Form Rating Scale 
 
 
Stool Form Rating Scale
? 1= separate hard lumps like 
nuts, 
2 = sausage shaped but lumpy, 
3 = like a sausage but with 
cracks on surface, 
4 = like a sausage, smooth and 
soft, 
5 = soft blobs with clear-cut 
edges, 
6 = fluffy pieces with ragged 
edges, 
7 =watery, solid pieces. 
?
?
?
?
?
?
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